
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253E8A8AF27973053E8A000731E297.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="rscadv">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="RSC Advances">
<meta name="citation_title" content="Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe">
<meta name="citation_author" content="Doaa A Elsayed">
<meta name="citation_author_institution" content="Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt">
<meta name="citation_author" content="Wael Shehta">
<meta name="citation_author_institution" content="Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt">
<meta name="citation_author" content="S El-Kalyoubi">
<meta name="citation_author_institution" content="Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt">
<meta name="citation_author" content="Adli Selim">
<meta name="citation_author_institution" content="Labelled Compounds Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt">
<meta name="citation_author" content="Mohammed G Assy">
<meta name="citation_author_institution" content="Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt">
<meta name="citation_author" content="Omar Metwally">
<meta name="citation_author_institution" content="Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt">
<meta name="citation_author" content="Ahmed A Al-Kubaisi">
<meta name="citation_author_institution" content="Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, 31001, Iraq, Email: doaaatef641995@gmail.com">
<meta name="citation_author" content="Sameer A Awad">
<meta name="citation_author_institution" content="Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, 31001, Iraq, Email: doaaatef641995@gmail.com">
<meta name="citation_author" content="F Marzook">
<meta name="citation_author_institution" content="Labelled Compounds Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="36">
<meta name="citation_firstpage" content="29544">
<meta name="citation_doi" content="10.1039/d5ra04955e">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/pdf/RA-015-D5RA04955E.pdf">
<meta name="description" content="This study successfully developed synthetic pathways for novel pyrimidine-based compounds for their potential anti-diabetic α-amylase inhibitory activity, aiming at potential antidiabetic applications. Molecular docking techniques showed that ...">
<meta name="og:title" content="Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study successfully developed synthetic pathways for novel pyrimidine-based compounds for their potential anti-diabetic α-amylase inhibitory activity, aiming at potential antidiabetic applications. Molecular docking techniques showed that ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12376908">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1039/d5ra04955e"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/RA-015-D5RA04955E.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12376908%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12376908/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12376908/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-rscadv.png" alt="RSC Advances logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to RSC Advances" title="Link to RSC Advances" shape="default" href="https://www.rsc.org/journals-books-databases/about-journals/rsc-advances/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">RSC Adv</button></div>. 2025 Aug 21;15(36):29544–29559. doi: <a href="https://doi.org/10.1039/d5ra04955e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1039/d5ra04955e</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22RSC%20Adv%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22RSC%20Adv%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22RSC%20Adv%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22RSC%20Adv%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elsayed%20DA%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Doaa A Elsayed</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Doaa A Elsayed</span></h3>
<div class="p">
<sup>a</sup>Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elsayed%20DA%22%5BAuthor%5D" class="usa-link"><span class="name western">Doaa A Elsayed</span></a>
</div>
</div>
<sup>a,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shehta%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Wael Shehta</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Wael Shehta</span></h3>
<div class="p">
<sup>a</sup>Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shehta%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wael Shehta</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Kalyoubi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">S El-Kalyoubi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">S El-Kalyoubi</span></h3>
<div class="p">
<sup>b</sup>Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Kalyoubi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">S El-Kalyoubi</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Selim%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Adli Selim</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Adli Selim</span></h3>
<div class="p">
<sup>c</sup>Labelled Compounds Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Selim%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adli Selim</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Assy%20MG%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mohammed G Assy</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mohammed G Assy</span></h3>
<div class="p">
<sup>a</sup>Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Assy%20MG%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammed G Assy</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Metwally%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Omar Metwally</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Omar Metwally</span></h3>
<div class="p">
<sup>a</sup>Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Metwally%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Omar Metwally</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al-Kubaisi%20AA%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ahmed A Al-Kubaisi</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ahmed A Al-Kubaisi</span></h3>
<div class="p">
<sup>d</sup>Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, 31001, Iraq, Email: doaaatef641995@gmail.com</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al-Kubaisi%20AA%22%5BAuthor%5D" class="usa-link"><span class="name western">Ahmed A Al-Kubaisi</span></a>
</div>
</div>
<sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Awad%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Sameer A Awad</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Sameer A Awad</span></h3>
<div class="p">
<sup>d</sup>Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, 31001, Iraq, Email: doaaatef641995@gmail.com</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Awad%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Sameer A Awad</span></a>
</div>
</div>
<sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marzook%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">F Marzook</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">F Marzook</span></h3>
<div class="p">
<sup>c</sup>Labelled Compounds Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marzook%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">F Marzook</span></a>
</div>
</div>
<sup>c</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="affa">
<sup>a</sup>Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt</div>
<div id="affb">
<sup>b</sup>Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt</div>
<div id="affc">
<sup>c</sup>Labelled Compounds Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt</div>
<div id="affd">
<sup>d</sup>Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, 31001, Iraq, Email: doaaatef641995@gmail.com</div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jul 11; Accepted 2025 Aug 14; Collection date 2025 Aug 18.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>This journal is © The Royal Society of Chemistry</div>
<p>This article is licensed under a <a href="https://creativecommons.org/licenses/by/3.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution 3.0 Unported Licence</a>. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12376908</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>This study successfully developed synthetic pathways for novel pyrimidine-based compounds for their potential anti-diabetic α-amylase inhibitory activity, aiming at potential antidiabetic applications. Molecular docking techniques showed that compounds 1, 6, and 8 showed the highest molecular docking <em>in silico</em> binding affinity, followed by <em>in vitro</em> estimation. Compound 1 showed the strongest inhibitory <em>in vitro</em> amylase effect, in comparison to the reference drug acarbose. According to <em>in silico</em> and <em>in vitro</em> combination, a novel radiolabeled compound, <sup>131</sup>Iodine-Compound 1, was chosen for further labeling study. The radiolabeling factors, including ligand concentration, pH, and reaction time, were adjusted to achieve maximum radiochemical yield and stability. For the <em>in vivo</em> behavior, biodistribution studies were estimated in mice up to a 36 hours period. The labelled compound showed significant and prolonged accumulation in the gastrointestinal tract, particularly the stomach and intestine, consistent with its proposed mechanism of enzyme inhibition. A gradual increase in muscle uptake was observed, raising possible insights into side effects reported with similar drugs. These results suggest that compound 1 not only possesses potent amylase-blocking and related effective antidiabetic activity but also holds promise as a molecular probe for molecular dynamic imaging for the GIT system.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p>An <sup>131</sup>I-labeled α-amylase inhibitor shows exceptional stomach retention (59.6% ID per g) and sustained intestinal uptake, highlighting its promise as a GI-targeted antidiabetic agent and potential GI imaging probe.<a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-ga.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/3c41e85e13c6/d5ra04955e-ga.jpg" loading="lazy" id="ga" height="378" width="654" alt="graphic file with name d5ra04955e-ga.jpg"></a></p></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Diabetes mellitus (DM) is recognized as one of the most significant global public health challenges. It is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both.<sup><a href="#cit1" class="usa-link" aria-describedby="cit1">1,2</a></sup> There are two main types: Type I diabetes, in which the pancreas produces little or no insulin, and Type II diabetes, where the body becomes resistant to insulin or fails to use it effectively. Although insulin is often still produced in type II cases, its proper utilization is impaired. The variability in insulin response remains an open research question, but contributing factors include obesity, physical inactivity, and genetic predisposition. Type II DM is associated with several comorbidities such as obesity, hypertension, dyslipidemia, and chronic kidney disease, increasing the risk of both acute and chronic complications, including premature mortality.<sup><a href="#cit3" class="usa-link" aria-describedby="cit3">3</a></sup> While lifestyle modifications and weight loss are essential for disease control, maintaining these changes long-term is challenging, and the risk of diabetes may persist even after successful weight management.<sup><a href="#cit4" class="usa-link" aria-describedby="cit4">4,5</a></sup> One therapeutic strategy for DM management involves inhibiting the enzyme α-amylase, which is responsible for catalyzing the breakdown of starch into glucose. Effective α-amylase inhibitors must possess suitable structural features to bind to the enzyme's active site and suppress its catalytic function. Several antidiabetic medications such as metformin, thiazolidinediones (TZDs), sulfonylureas, DPP-4 inhibitors, insulin, and GLP-1 analogs are widely used, yet most are associated with side effects and fail to achieve optimal glycemic control in many patients.<sup><a href="#cit6" class="usa-link" aria-describedby="cit6">6</a></sup> Consequently, there is a growing interest in developing new antidiabetic agents with improved safety and efficacy profiles. Heterocyclic pyrimidine derivatives have shown promise as bioactive scaffolds due to their diverse biological properties.<sup><a href="#cit7" class="usa-link" aria-describedby="cit7">7–12</a></sup> Pyrimidine rings, being fundamental components of nucleic acids, hold particular importance in medicinal chemistry, and several pyrimidine-based compounds have been investigated as potential enzyme inhibitors for diabetes treatment.</p>
<p>Molecular docking and <em>in silico</em> modeling can help elucidate the mechanism of action of novel pyrimidine derivatives by predicting their binding interactions with target proteins. Previous studies<sup><a href="#cit13" class="usa-link" aria-describedby="cit13">13–19</a></sup> have employed molecular docking to examine protein-ligand interactions at the atomic level, aiding in the rational design of drug candidates. In this study, synthesized pyrimidine-based compounds were docked against the α-amylase active site (PDB ID: 5E0F)<sup><a href="#cit20" class="usa-link" aria-describedby="cit20">20</a></sup> aiming to identify promising inhibitors.</p>
<p>To further support the biological relevance of the most active compound, a novel radiolabeled derivative (<sup>131</sup>I-pyrimidine) was synthesized. Key radiolabeling parameters, including ligand concentration, pH, reaction temperature, and incubation time, were optimized to ensure high radiochemical yield and <em>in vitro</em> stability. <em>In vitro</em> α-amylase inhibition assays were conducted to evaluate antidiabetic potential, while <em>in vivo</em> biodistribution studies in normal mice were carried out to investigate tissue uptake, pharmacokinetics, and gastrointestinal targeting of the radiolabeled compound.<sup><a href="#cit21" class="usa-link" aria-describedby="cit21">21–26</a></sup> This integrative study combining synthetic chemistry, computational modeling, biological assays, and radiotracing techniques aims to identify and characterize novel pyrimidine-based α-amylase inhibitors with potential dual roles as therapeutic agents and diagnostic imaging probes for diabetes management.</p></section><section id="sec2"><h2 class="pmc_sec_title">Experimental</h2>
<section id="sec3"><h3 class="pmc_sec_title">General information</h3>
<p>Starting materials, solvents, and reagents were bought from reputable vendors, including Sigma-Aldrich, Loba, Merck, Acros, and El-Gomhoria. The melting points (°C) were obtained with open capillaries using a Stuart SMP10 melting point instrument and are uncorrected. NMR spectra were acquired on a Bruker high-performance digital FT-NMR spectrometer advance III 400 MHz for <sup>1</sup>H NMR and 100 MHz for <sup>13</sup>C NMR (see supplementary information for the spectra). Dimethyl sulfoxide (DMSO)-d<sub>6</sub> was used as a solvent and tetramethyl silane (TMS) as an internal standard. Radiolabeling: All chemicals and solvents were purchased from Merck Co. Whatman. No. 1 paper chromatography (PC) was exported and supplied by Merck Co. 131-Iodine was purchased from RBF-EAEA. An NaI:Tl scintillator (Scaler Ratemeter SR7 model, England) was used for measuring <em>γ</em>-ray radioactivity counts. Double distilled water was used for the preparation of all solutions, and all other chemicals but all reagents consumed in this study were of the analytical grade, used without further purification. α-Amylase Inhibition Assay: The α-amylase inhibition assay was performed using the 3,5-dinitrosalicylic acid (DNSA) method.<sup><a href="#cit21" class="usa-link" aria-describedby="cit21">21</a></sup></p></section><section id="sec4"><h3 class="pmc_sec_title">Chemistry</h3>
<section id="sec5"><h4 class="pmc_sec_title">1,1′-(5,8-Dihydroxy-2-oxo-6a-phenyl-2,3,3a1,6a-tetrahydro-1<em>H</em>-perimidine-6,7-diyl)bis(ethan-1-one) (1)</h4>
<p>A mixture of (0.01 mol) of 5-benzylidene barbituric acid with (0.02 mol) of acetyl acetone and TiO<sub>2</sub> (1.5 mg) as a nanocatalyst was refluxed in (10 ml) of dimethylformamide as a solvent for 6 hours, then the mixture was filtered to remove TiO<sub>2</sub>, and then the filtrate was cooled down till solid precipitate was formed. Then the mixture was filtrated, the solid precipitate was collected and dried, and then recrystallized from absolute ethanol, and yellow powder was collected. The percentage of the yield is 98%, and the melting point is (230 °C). I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3492 (OH), 3190 (NH), 3059–2847 (CH for aromatic and aliphatic), 1752 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O), 1679 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>N), 1561, 1492 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>C aromatic). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 2.06 (s, 6H, CH<sub>3</sub>), 2.88 (s, 1H, CH), 6.89 (s, 2H, 2CH<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>), 7.11–7.35 (m, 5H, Harom), 8.70–8.77 (s, 2H, 2NH), 11.67–11.78 ppm (s, 2H, 2OH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 34.44, 36.62, 50.16, 109.00, 126.76, 129.83, 129.94, 131.08, 143.11, 148.82, 148.92, 162.36, 172.36 ppm. MS (ESI<sup>+</sup>), <em>m</em>/<em>z</em>: 378.33 (M<sup>+</sup>).</p></section><section id="sec6"><h4 class="pmc_sec_title">Diethyl 2,5,8-trioxo-6a-phenyl-2,3,4,5,6,6a,7,8-octahydro-1<em>H</em>-perimidine-6,7-dicarboxylate (2)</h4>
<p>A solution of target (A) (.01 mol) and ethyl acetoacetate (.02 mol) and (1.5 mg) of TiO<sub>2</sub> was refluxed in (10 ml) of DMF for 6 h, then the mixture was filtrated to remove TiO<sub>2</sub>; then it was poured into ice till precipitated, then the mixture was filtrated and the precipitate was collected and dried. Recrystallization occurred by absolute ethanol, then a brown ppt was collected and dried, m.p. is (240 °C). The percentage of the yield is (97.5%). IR. (KBr, <em>υ</em> cm<sup>−1</sup>): 3112 (NH), 3057–2837 (CH for aromatic and aliphatic), 1752 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O), 1702 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O), 1679 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 1.05–1.08 (t, 6H, 2CH<sub>3</sub>), 2.45–2.50 (q, 4H, 2CH<sub>2</sub>), 3.76–3.78 (d, 1H, CH), 4.00–4.02 (d, 1H, CH), 4.82 (s, 2H, 2CH), 7.13–7.32 (m, 5H, Harom), 11.46 (s, 2H, 2NH). <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 8.63, 18.56, 48.87, 58.84, 59.24, 100.04, 127.80, 128.11, 128.78, 137.57, 148.79, 162.32, 170.87, 172.77, 207.19, 208.99 ppm.</p></section><section id="sec7"><h4 class="pmc_sec_title">8-Hydroxy-2,5-dioxo-6a-phenyl-2,3,4,5,6,6a-hexahydro-1<em>H</em>-pyrimido[4,5,6-<em>ij</em>][2,7]naphthyridine-6,7-dicarbonitrile (3)</h4>
<p>A mixture of (0.01 mol) of 5-benzylidene barbituric acid with (0.02 mol) of cyanoacetamide and TiO<sub>2</sub> (1.5 mg) as a nanocatalyst was refluxed in (10 ml) of dimethylformamide as a solvent for 6 hours, then the mixture was filtered to remove TiO<sub>2</sub>, and then the filtrate was poured onto ice till cooled down, and then solid precipitate was formed. The mixture was filtrated, the solid precipitate was collected and dried, and then recrystallized from absolute ethanol, and yellow powder was collected. The percentage of the yield is (98.6%) and the melting point is (300 °C). IR. (KBr, <em>υ</em> cm<sup>−1</sup>): 3473 (OH), 3.317–3219 (3NH), 3054–2929 (CH for aromatic and aliphatic), 2200 (CN), 1623 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 3.95 (s, 1H, CH), 7.14–7.42 (m, 5H, Harom), 9.14 (s, 2H, 2NH), 10.85 (s, H, NH), 13.34 (s, H, OH).</p></section><section id="sec8"><h4 class="pmc_sec_title">5,8-Dihydroxy-2-oxo-6a-phenyl-2,3,4,6a-tetrahydro-1<em>H</em>-pyrimido[4,5,6-<em>ij</em>][2,7]naphthyridine-6,7-dicarboxamide (4)</h4>
<p>A solution of target (A) (.01 mol) and monoamide (.02 mol) and (1.5 mg) of TiO<sub>2</sub> was refluxed in (10 ml) of DMF for 6 h, then the mixture was filtrated to remove TiO<sub>2</sub>. Then it was poured into ice till precipitated, then the mixture was filtrated, and the precipitate was collected and dried. Recrystallization occurred by absolute ethanol, then a yellow ppt was collected and dried, m.p. is (300 °C), and the percentage of the yield is (96%). IR. (KBr, <em>υ</em> cm<sup>−1</sup>): 3473 (OH), 3351 (NH), 3159 (NH<sub>2</sub>), 3007–2818 (CH for aromatic and aliphatic), 1615 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 7.18 (s, 4H, 2NH<sub>2</sub>), 7.57–7.66 (m, 5H, Harom), 8.04–8.06 (s, 3H, 3NH), 11.53 (s, 2H, 2OH).</p></section><section id="sec9"><h4 class="pmc_sec_title">5,8-Diamino-2-oxo-6a-phenyl-1,6a-dihydro-2<em>H</em>-4,9-dioxa-1,3-diazaphenalene-6,7-dicarbonitrile (5)</h4>
<p>A mixture of (0.01 mol) of 5-benzylidene barbituric acid with (0.02 mol) of malononitrile and TiO<sub>2</sub> (1.5 mg) as a nanocatalyst was refluxed in (10 ml)as a solvent for 6 hours, then the mixture was filtered to remove TiO<sub>2</sub>, and then the filtrate was poured onto ice till cooled down. Then solid precipitate was formed, the mixture was filtrated, the solid precipitate was collected and dried, and then recrystallized from absolute ethanol, and yellow powder was collected. The percentage of the yield is (97.3%) and the melting point is (120 °C) .I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3383 (NH), 3281–3132 (NH<sub>2</sub>), 3107–2964 (CH for aromatic and aliphatic), 2221 (CN), 1677 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 6.50 (s, 4H, 2NH<sub>2</sub>), 7.43–7.51 (m, 5H, Harom), 9.98 (s, 1H, NH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 29.00, 36.93, 38.99, 39.36, 129.42, 129.36, 129.93, 132.91, 133.03, 149.95, 154.94, 155.33, 157.92, 164.98 ppm. MS (ESI<sup>+</sup>), <em>m</em>/<em>z</em>: 346.81 (M<sup>+</sup>).</p></section><section id="sec10"><h4 class="pmc_sec_title">3,3,11,11-Tetramethyl-13b-phenyl-3,4,10,11,12,13b-hexahydro-1<em>H</em>-5,9-dioxa-6,8-diazanaphtho[3,2,1-<em>de</em>]anthracene-1,7,13(2<em>H</em>,6<em>H</em>)-trione (6)</h4>
<p>A mixture of (0.01 mol) of 5-benzylidene barbituric acid with (0.02 mol) of dimedone and TiO<sub>2</sub> (1.5 mg) as a nanocatalyst was refluxed in (10 ml) of dimethylformamide as a solvent for 6 hours, then the mixture was filtered to remove TiO<sub>2</sub>, and then the filtrate was poured onto ice till cooled down. Then solid precipitate was formed, the mixture was filtrated, the solid precipitate was collected and dried, and then recrystallized from absolute ethanol, and yellow powder was collected. The percentage of the yield is 98.9%, and the melting point is (200 °C) .I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3152 (NH), 1761 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O), 1678 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 0.88 (s, 12H, 4CH<sub>3</sub>), 2.05 (s, 4H, 2CH<sub>2</sub>), 2.23 (s, 4H, 2CH<sub>2</sub>), 7.15–7.22 (m, 5H, Harom), 9.89 (s, 1H, NH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 26.68, 28.77, 31.21, 31.85, 50.08, 82.63, 110.54, 114.41, 126.17, 128.03, 139.33, 144.42, 150.67, 156.26, 162.91, 180.03, 195.05 ppm. MS (ESI<sup>+</sup>), <em>m</em>/<em>z</em>: 458.61 (M<sup>+</sup>).</p></section><section id="sec11"><h4 class="pmc_sec_title">11b-phenyl-2,3,9,10,11,11b-hexahydro-1<em>H</em>-4,8-dioxa-5,7-diazadicyclopenta[<em>a</em>,<em>j</em>]phenalen-6(5<em>H</em>)-one (7)</h4>
<p>A solution of target (A) (0.01 mole) and cyclopentanone (0.02 mole) and (1.5 mg) of TiO<sub>2</sub> was refluxed in (10 ml) of DMF for 6 h, then the mixture was filtered to remove TiO<sub>2</sub>, then it was poured into ice till precipitated, then the mixture was filtered and the precipitate was collected and dried. Recrystallization occurred by absolute ethanol, then a yellow ppt was collected and dried, m.p. is (150 °C), and the percentage of the yield is (96.8%). I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3191 (NH), 3022–2957 (CH for aromatic and aliphatic), 1683 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 2.67–2.75 (t, 4H, 2CH<sub>2</sub>), 2.84–2.95 (t, 4H, 2CH<sub>2</sub>), 3.22–3.50 (m, 4H, 2CH<sub>2</sub>), 7.24–7.52 (m, 5H, Harom), 11.45 (s, 1H, NH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 24.28, 30.52, 34.74, 36.17, 80.12, 114.41, 116.52, 128.32, 129.36, 134.28, 135.71, 137.44, 159.42, 162.61, 179.38 ppm.</p></section><section id="sec12"><h4 class="pmc_sec_title">3a-Phenyl-3a,7-dihydro-1<em>H</em>-1,3,4,6,7,9-hexaazaphenalene-2,5,8(3<em>H</em>,4<em>H</em>,6<em>H</em>)-trione (8)</h4>
<p>A solution of target (A) (.01 mole) and urea (.02 mole) and (1.5 mg) of TiO<sub>2</sub> was refluxed in (10 ml) of DMF for 6 h, then the mixture was filtered to remove TiO<sub>2</sub>, then it was poured into ice till precipitated, then the mixture was filtered and the precipitate was collected and dried. Recrystallization occurred by absolute ethanol, then a yellow ppt was collected and dried. The m.p. is (above 300 °C), and the percentage of the yield is (98.6%). I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3398 (NH), 3022–2821 (CH for aromatic and aliphatic), 1614 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 7.96–8.07 (m, 5H, Harom), 9.14 (s, 2H, 2NH), 9.38 (s, 2H, 2NH), 10.60 (s, 1H, NH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 77.44, 89.22, 122.30, 129.41, 129.33, 137.31, 143.73, 150.12, 153.40, 163.51, 169.89 ppm.</p></section><section id="sec13"><h4 class="pmc_sec_title">2a-Phenyl-2a,2a1,7,7a-tetrahydro-6<em>H</em>-1,2,3,4,5,7-hexaazacyclopenta[<em>cd</em>]inden-6-one (9)</h4>
<p>A mixture of 0.01 mol of 5-benzylidene barbituric acid with 0.02 mol of hydrazine and TiO<sub>2</sub> (1.5 mg) as a nanocatalyst was refluxed in 10 ml of dimethylformamide as a solvent for 6 hours, then the mixture was filtered to remove TiO<sub>2</sub>, and then the filtrate was poured into ice till cooled down. Then solid precipitate was formed, the mixture was filtrated, the solid precipitate was collected and dried, and then recrystallized from absolute ethanol, and yellow powder was collected. The percentage of the yield is 98.1%, and the melting point is (80 °C). I.R. (KBr, <em>υ</em> cm<sup>−1</sup>): 3160 (NH), 1646 (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O). <sup>1</sup>H NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 7.15 (m, 5H, Harom), 8.71 (s, 1H, NH); <sup>13</sup>C NMR (DMSO-d<sub>6</sub>): <em>δ</em> = 89.15, 102.10, 128.34, 129.01, 131.08, 133.78, 161.45, 166.02 ppm.</p></section></section><section id="sec14"><h3 class="pmc_sec_title">ADMET properties</h3>
<p>The tools utilized for POM analysis, particularly MOLINSPIRATION<sup><a href="#cit27" class="usa-link" aria-describedby="cit27">27</a></sup> and ProTox-II,<sup><a href="#cit28" class="usa-link" aria-describedby="cit28">28</a></sup> follow the same fundamental premise. The molecular structure is first established by drawing it or inputting its SMILES code. The specific parameters are then calculated using the fragment system.,<sup><a href="#cit29" class="usa-link" aria-describedby="cit29">29,30</a></sup> followed by molecular modeling for the most active chemicals using the molecular operating environment software.<sup><a href="#cit31" class="usa-link" aria-describedby="cit31">31–35</a></sup></p></section><section id="sec15"><h3 class="pmc_sec_title">Preparation of protein</h3>
<p>Chemdraw 12.0 was used to sketch the molecular modeling for the most active chemicals to be docked by using Molecular Operating Environment software (2022). The results were refined using the London DG force and force field energy. MMFF 94 (Merck molecular force field 94) was used to complete all minimizations until a root mean square deviation (RMSD) gradient of 0.1 kcal mol<sup>−1</sup> A<sup>−1</sup> was reached,<sup><a href="#cit36" class="usa-link" aria-describedby="cit36">36–38</a></sup> and the partial charges were determined automatically. The MOE software's scoring function, dock function (<em>S</em>, kcal mol<sup>−1</sup>), was used to determine the ligand's binding affinity. The X-ray crystal structure of the enzyme was retrieved in PDB format from the protein data bank (PDB ID: 5E0F, resolution: 1.40) (<a href="https://www.rcsb.org/structure/5E0F" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.rcsb.org/structure/5E0F</a>). The enzyme was prepared for docking studies by removing water, adding all hydrogen bonds, fixing potential, and generating dummy atoms from the resulting alpha spheres<sup><a href="#cit33" class="usa-link" aria-describedby="cit33">33,39</a></sup> then analyzing the ligand's interaction with the active site's amino acids. The best docking score is obtained as the most negative value for the active ligands.<sup><a href="#cit40" class="usa-link" aria-describedby="cit40">40,41</a></sup></p></section><section id="sec16"><h3 class="pmc_sec_title">Radiolabeling procedure</h3>
<p>Radiolabeling was performed using the direct labeling method, with the pH of the preparation adjusted, followed by incubation at room temperature for a specified reaction time. The effects of ligand concentrations (1 mg ml<sup>−1</sup> ethanol), reaction time, and pH on radiolabeling efficiency were optimized to establish optimal reaction conditions.<sup><a href="#cit21" class="usa-link" aria-describedby="cit21">21–26</a></sup></p>
<p>The chemical identity and radiochemical purity of [<sup>131</sup>I]–Compound 1 were confirmed using co-thin layer chromatography (co-TLC) with the corresponding non-radioactive standard. Silica gel TLC plates were developed in chloroform:methanol (3 : 1, v/v) as the mobile phase. [<sup>131</sup>I]–Compound 1 exhibited an <em>R</em><sub>f</sub> value of 0.70, identical to that of the cold standard, whereas free iodide remained at the origin (<em>R</em><sub>f</sub> = 0.0). This result confirms the successful labeling of Compound 1 and the absence of unbound [<sup>131</sup>I], in agreement with previously reported TLC-based radiolabeling confirmation methods.<sup><a href="#cit42" class="usa-link" aria-describedby="cit42">42</a></sup></p></section><section id="sec17"><h3 class="pmc_sec_title">Animal studies</h3>
<p>Quantitative biodistribution studies were carried out using male Swiss albino mice (20–25 g), purchased from the Animal House of the labelled compounds department. Mice were kept under standard laboratory conditions ad libitum. Minimizing animal scarification Efforts were carefully made to minimize the number of animals utilized, under EAEA license number P/99A/24 from NCRRT. Mice were kept in a comfortable environment, including nesting materials and tunnels, with suitable cages to reduce stress.<sup><a href="#cit26" class="usa-link" aria-describedby="cit26">26,43,44</a></sup></p>
<p>Biodistribution studies were conducted <em>via</em> intravenous (IV) administration in normal mice. Each mouse received an oral injection of 0.05 ml containing 0.74 MBq per μmol of the radiolabeled complex using yellow tips of an automated micropipette. Mice were maintained for predefined time intervals, after which tissue distribution was assessed. Mice were sacrificed at 1, 2, 4, 8, 12-, 16-, 24-, and 36 hours post-injection (p.i). A total number of 40 animals were divided into 8 groups, with 5 mice per time interval. Organs were dissected and weighed, and their radioactivity was counted by using a <em>γ</em>-ray scintillation counter. The percentage of injected dose (% ID per g) was calculated for each sample using a standard equation. At each time point, mice were weighed and anesthetized using a ketamine/xylazine combination before being sacrificed <em>via</em> cervical dislocation. The administered anesthesia doses were Ketamine: 75–100 mg kg<sup>−1</sup> and Xylazine: 5–10 mg kg<sup>−1</sup>. Cervical dislocation was used for scarification to confirm merciful death before tissue collection. All carcasses and tissues containing radioactive material were handled in compliance with the Egyptian Atomic Energy Authority guidelines.<sup><a href="#cit45" class="usa-link" aria-describedby="cit45">45–48</a></sup></p></section><section id="sec18"><h3 class="pmc_sec_title">Statistical treatment of biological data</h3>
<section id="sec19"><h4 class="pmc_sec_title">Radiolabeling</h4>
<p>Optimized at pH 4, 200 μg ml<sup>−1</sup> Compound 1, 30 min, 25 °C (<em>n</em> = 3, <em>p</em> &lt; 0.01).</p></section><section id="sec20"><h4 class="pmc_sec_title">α-Amylase assay</h4>
<p>IC<sub>50</sub> calculated <em>via</em> nonlinear regression (GraphPad Prism v9.0), triplicate experiments.</p></section><section id="sec21"><h4 class="pmc_sec_title">Biodistribution</h4>
<p>Data expressed as mean ± SEM (<em>n</em> = 5/group), analyzed by ANOVA + Tukey's test.</p></section></section></section><section id="sec22"><h2 class="pmc_sec_title">Results and discussion</h2>
<section id="sec23"><h3 class="pmc_sec_title">Chemistry</h3>
<p>1,1′-(5,8-Dihydroxy-2-oxo-6a-phenyl-2,3,3a1,6a-tetrahydro-1<em>H</em>-perimidine-6,7-diyl)bis(ethan-1-one), a novel perimidine derivative, was successfully synthesized in this study using a one-pot multicomponent reaction that involved 5-benzylidene barbituric acid, acetylacetone, and TiO<sub>2</sub> nanoparticles as a nanocatalyst under reflux in dimethylformamide (DMF). The final polyfunctionalized heterocyclic scaffold is the result of a sequential Michael addition, intramolecular cyclization, and 1,3-sigmatropic rearrangement, as shown in the suggested scheme. Because of the nanomaterial's high catalytic effectiveness and increased surface area, which facilitate the activation of carbonyl groups and promote the synthesis of intermediates, the introduction of TiO<sub>2</sub> nanoparticles greatly raised the reaction yield (98%) and decreased the reaction time, <a href="#sch1" class="usa-link">Scheme 1</a>. Several spectroscopic methods were used to validate the synthesized compound's structure. The O–H and N–H stretching vibrations are represented by the distinctive absorption bands in the infrared spectra, which were found at 3492 cm<sup>−1</sup> and 3190 cm<sup>−1</sup>, respectively. While the peaks at 1561 and 1492 cm<sup>−1</sup> verify the presence of aromatic C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>C bonds, the strong bands at 1752 cm<sup>−1</sup> and 1679 cm<sup>−1</sup> are ascribed to the stretching vibrations of the conjugated carbonyl (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O) and imine (C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>N) functionalities. Acetyl methyl and methine groups were detected by the <sup>1</sup>H NMR spectra (DMSO-d<sub>6</sub>), which showed singlets at <em>δ</em> = 2.06 ppm (6H, CH<sub>3</sub>) and <em>δ</em> = 2.88 ppm (1H, methine proton). The aromatic protons resonated as a multiplet in the range of <em>δ</em> = 7.11–7.35 ppm (5H), whereas the olefinic protons showed up as singlets at <em>δ</em> = 6.89 ppm (2H). Downfield signals at <em>δ</em> = 8.70–8.77 ppm (2H, NH) and <em>δ</em> = 11.67–11.78 ppm (2H, OH) verified that the heterocyclic ring included hydrogen-bonded protons. Additionally, signals corresponding to methyl (<em>δ</em> = 34.44, 36.62), methine (<em>δ</em> = 50.16), aromatic/olefinic carbons (<em>δ</em> = 109.00–143.11), imine, and carbonyl carbons (<em>δ</em> = 148.82–172.36) were found in the <sup>13</sup>C NMR spectra, which confirmed the given structure. The ESI<sup>+</sup> mass spectrum's molecular ion peak, which is detected at <em>m</em>/<em>z</em> = 378.33 (M<sup>+</sup>), validates the target compound's effective synthesis by confirming the product's molecular weight.</p>
<figure class="fig xbox font-sm" id="sch1"><h4 class="obj_head">Scheme 1. Cyclization of 5-benzyldine barbituric acid with acetylacetone.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-s1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/4a9dadc6d091/d5ra04955e-s1.jpg" loading="lazy" height="603" width="734" alt="Scheme 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Using 5-benzylidene barbituric acid as the primary substrate, a number of pyrimidine derivatives were effectively produced by multicomponent reactions that were TiO<sub>2</sub> nanocatalyzed. Target compounds (2–5) are produced under moderate circumstances utilizing TiO<sub>2</sub> nanoparticles (1.5 mg) as an effective and recyclable heterogeneous catalyst in DMF at reflux for 6 hours, as shown in the schematic approach 2. Because of their large surface area, Lewis acidity, and superior dispersion in polar fluids, TiO<sub>2</sub> nanoparticles were essential in increasing reaction speeds and yields (96–98.6%). Through the processes of Knoevenagel condensation, Michael addition, and intramolecular cyclization, these properties promoted the creation of pyrimido[4,5,6-<em>ij</em>][2,7]naphthyridine and perimidine frameworks by effectively activating carbonyl and nitrile groups. The presence of multiple carbonyl functionalities was confirmed by the characteristic IR absorption bands for NH (3112 cm<sup>−1</sup>), aliphatic/aromatic C–H (3057–2837 cm<sup>−1</sup>), and strong carbonyl stretches (1752, 1702, 1679 cm<sup>−1</sup>) displayed by compound 2, diethyl 2,5,8-trioxo-6a-phenyl-2,3,4,5,6,6a,7,8-octahydro-1<em>H</em>-perimidine-6,7-dicarboxylate. Ethyl groups were represented as triplets and quartets in the <sup>1</sup>H NMR spectrum at <em>δ</em> 1.05–2.50 ppm, while aromatic protons were seen as a multiplet at <em>δ</em> 7.13–7.32 ppm. NH groups were detected in two singlets at <em>δ</em> 11.46 ppm. The structure was further validated by <sup>13</sup>C NMR, which showed distinctive signals for aliphatic, aromatic, and carbonyl (<em>δ</em> ∼172–209 ppm) carbons. 8-Hydroxy-2,5-dioxo-6a-phenyl-2,3,4,5,6,6a-hexahydro-1<em>H</em>-pyrimido [4,5,6-<em>ij</em>] is compound 3. The stretching vibrations of hydroxyl (3473 cm<sup>−1</sup>), NH (3219–3317 cm<sup>−1</sup>), aromatic/aliphatic C–H (3054–2929 cm<sup>−1</sup>), and nitrile (2200 cm<sup>−1</sup>) were clearly visible in [2,7]naphthyridine-6,7-dicarbonitrile. The cyclization and nitrile substitution were verified by the IR and NMR. A tricyclic naphthyridine system was supported by the <sup>1</sup>H NMR spectra, which revealed a downfield singlet for OH at <em>δ</em> 13.34 ppm and extra NH protons at <em>δ</em> 9.14 and 10.85 ppm. The effective insertion of amide functionalities was demonstrated by Compound 4, a dihydroxy-dicarboxamide derivative, which showed IR absorptions for OH (3473 cm<sup>−1</sup>), NH and NH<sub>2</sub> groups (3351, 3159 cm<sup>−1</sup>), and C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O (1615 cm<sup>−1</sup>). In addition to aromatic protons, the <sup>1</sup>H NMR verified this with singlets at <em>δ</em> 7.18 ppm for NH<sub>2</sub> and <em>δ</em> 11.53 ppm for hydroxyl groups. The high yield (96%) and melting point provided additional evidence of the nanocatalyst's effectiveness in creating highly functionalized heterocycles. In addition to a prominent nitrile band at 2221 cm<sup>−1</sup> and C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O at 1677 cm<sup>−1</sup>, compound 5, the diamino-dicyano derivative, showed IR bands for NH and NH<sub>2</sub> at 3383 and 3281–3132 cm<sup>−1</sup>. NH at <em>δ</em> 9.98 ppm, aromatic multiplet at <em>δ</em> 7.43–7.51 ppm, and NH<sub>2</sub> protons at <em>δ</em> 6.50 ppm were all visible in the <sup>1</sup>H NMR spectrum. Signals for nitrile, carbonyl, and aromatic carbons were detected by <sup>13</sup>C NMR. The estimated molecular ion peak and the mass spectrum (<em>m</em>/<em>z</em> = 346.81) agreed, indicating molecular integrity (<a href="#sch2" class="usa-link">Scheme 2</a>).</p>
<figure class="fig xbox font-sm" id="sch2"><h4 class="obj_head">Scheme 2. Cyclization of 5-benzylidenepyrimidine-2,4,6(1<em>H</em>,3<em>H</em>,5<em>H</em>)-trione with reagent bearing active methylene group.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-s2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/7a7d32e3f416/d5ra04955e-s2.jpg" loading="lazy" height="747" width="734" alt="Scheme 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Using 5-benzylidene barbituric acid as a crucial intermediate and a variety of nucleophilic partners, including dimedone, cyclopentanone, urea, and hydrazine hydrate, a multicomponent reaction was used to create a number of new fused heterocyclic systems (compounds 6–9). TiO<sub>2</sub> nanoparticles (1.5 mg) were used as an effective nanocatalyst. For six hours, reactions were conducted in DMF under reflux conditions. Because of their large surface area and improved catalytic qualities, which allow for efficient interaction with reactants and facilitate bond formation <em>via</em> Knoevenagel–Michael-type sequences and intramolecular cyclizations, TiO<sub>2</sub> NPs greatly increased yield (96.8–98.9%) and decreased reaction time. IR revealed a wide NH band at 3152 cm<sup>−1</sup> and significant C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O absorptions at 1761 and 1678 cm<sup>−1</sup> for compound 6, which was created by interaction with dimedone. In addition to a singlet for NH at 9.89 ppm, the <sup>1</sup>H NMR spectra verified the existence of four methyl groups (<em>δ</em> = 0.88 ppm, 12H), methylene protons (<em>δ</em> = 2.05, 2.23 ppm), and aromatic protons (<em>δ</em> = 7.15–7.22 ppm). A molecular ion peak at <em>m</em>/<em>z</em> 458.61 was visible in the MS spectra, which was in line with the predicted mass. The IR bands for NH (3191 cm<sup>−1</sup>), aromatic/aliphatic C–H (3022–2957 cm<sup>−1</sup>), and C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O (1683 cm<sup>−1</sup>) were seen in compound 7, which was created using cyclopentanone. The cyclopentyl CH<sub>2</sub> protons (<em>δ</em> = 2.67–3.50 ppm) were found to have complex multiplets in <sup>1</sup>H NMR, coupled with aromatic protons and a downfield NH signal at 11.45 ppm. The aliphatic CH<sub>2</sub>, quaternary carbons, and carbonyl groups were represented by peaks in the <sup>13</sup>C NMR spectra, which supported the production of a fused dicyclopenta[<em>a</em>,<em>j</em>]phenalene skeleton. In the IR spectra, compound 8, which was the result of a reaction with urea, had a high NH absorption at 3398 cm<sup>−1</sup> and C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O at 1614 cm<sup>−1</sup>. Multiple NH protons in a polyazaphenalene framework were indicated by the distinctive NH signals at <em>δ</em> = 9.14, 9.38, and 10.60 ppm in the <sup>1</sup>H NMR spectra. The appearance of aromatic protons occurred around <em>δ</em> = 7.96–8.07 ppm. The hexacyclic trione structure was supported by the <sup>13</sup>C NMR spectra, which verified the existence of carbonyl carbons, heteroaromatic rings, and sp<sup>2</sup> carbons. In the infrared spectra, compound 9, which was made using hydrazine, displayed a C<span aria-roledescription="private character" aria-label="DOUBLE BOND, LENGTH AS M-DASH" aria-description="double bond, length as m-dash">

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>

</span>O band at 1646 cm<sup>−1</sup> and a single NH stretch at 3160 cm<sup>−1</sup>. Aromatic protons at <em>δ</em> = 7.15 ppm and a singlet NH at 8.71 ppm were detected by the <sup>1</sup>H NMR. The development of a hexaazacyclopenta[<em>cd</em>]indene framework was confirmed by the carbon spectra, which showed peaks at <em>δ</em> = 89.15 and 102.10 ppm that corresponded to freshly produced heterocyclic carbons together with aromatic and carbonyl carbon signals (<a href="#sch3" class="usa-link">Scheme 3</a>).</p>
<figure class="fig xbox font-sm" id="sch3"><h4 class="obj_head">Scheme 3. Heterocyclization of 25-benzylidenepyrimidine-2,4,6(1<em>H</em>,3<em>H</em>,5<em>H</em>)-trione with cyclic ketones and binucleophilic nitrogen.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-s3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/954039529c85/d5ra04955e-s3.jpg" loading="lazy" height="735" width="729" alt="Scheme 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec24"><h3 class="pmc_sec_title">Analysis of ADME characteristics of ligand</h3>
<p>POM analysis and other comparable procedures are useful for identifying various physicochemical properties and anticipating a molecule's biological activity, ADME parameters, and toxicity. Compounds 1, 2, and 6 underwent a modified POM analysis using the MOLINSPIRATION tools.</p></section><section id="sec25"><h3 class="pmc_sec_title">Molinsipration calculation</h3>
<p>MOLINSPIRATION offers a comprehensive range of computational biology applications to assist with molecular manipulation and processing. These tools include SMILES and Sdfile conversion, molecule normalization, tautomer generation, molecule fragmentation, calculation of various molecular properties required for QSAR, molecular modeling and drug design, high-quality molecule depiction, and molecular database tools that aid in substructure and similarity searches.<sup><a href="#cit15" class="usa-link" aria-describedby="cit15">15,49</a></sup></p>
<p>
<a href="#tab1" class="usa-link">Table 1</a> shows the predicted pharmacokinetic/molinspiration characteristics for compounds produced 1, 2, and 6. Using Molinspiration online screening, virtually all of the compounds created have potential biological activity, as evidenced by the docking parameters in <a href="#tab2" class="usa-link">Table 2</a>, which highlight drug-like characteristics against kinase inhibitors, proteases, and enzyme inhibitors. The calculated distribution of activity scores (version 2022.08) is contrasted with scores for GPCR ligands, kinase inhibitors, ion channel modulators, nuclear receptor ligands, protease inhibitors, and other enzyme targets. These ratings include scores for more than 100 000 typical drug-like substances. The score allows for effective distinction of active and inactive compounds.</p>
<section class="tw xbox font-sm" id="tab1"><h4 class="obj_head">Table 1. Physicochemical properties of the synthesized compounds<a href="#tab1fna" class="usa-link"><sup>a</sup></a>.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1">Compound</th>
<th rowspan="1" colspan="1">Mi Log <em>P</em>
</th>
<th rowspan="1" colspan="1">TPSA</th>
<th rowspan="1" colspan="1">
<em>n</em>-atoms</th>
<th rowspan="1" colspan="1">M.W.</th>
<th rowspan="1" colspan="1">
<em>n</em>ON</th>
<th rowspan="1" colspan="1">
<em>n</em>OHNH</th>
<th rowspan="1" colspan="1">
<em>n</em>-violations</th>
<th rowspan="1" colspan="1">
<em>n</em>-rotb</th>
<th rowspan="1" colspan="1">Volume</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1.96</td>
<td align="center" rowspan="1" colspan="1">115.72</td>
<td rowspan="1" colspan="1">28</td>
<td align="center" rowspan="1" colspan="1">378.38</td>
<td align="center" rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">4</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">325.43</td>
</tr>
<tr>
<td rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2.74</td>
<td align="center" rowspan="1" colspan="1">141.72</td>
<td rowspan="1" colspan="1">32</td>
<td align="center" rowspan="1" colspan="1">438.44</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td rowspan="1" colspan="1">4</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">7</td>
<td align="center" rowspan="1" colspan="1">307.00</td>
</tr>
<tr>
<td rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">4.49</td>
<td align="center" rowspan="1" colspan="1">98.36</td>
<td rowspan="1" colspan="1">34</td>
<td align="center" rowspan="1" colspan="1">458.51</td>
<td align="center" rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">405.63</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tab1fna">
<sup>a</sup><p class="display-inline">Abbreviations: Mi log <em>P</em>, logarithm of partition coefficient of compound between <em>n</em>-octanol and water; MV, molecular volume; MW, molecular weight; <em>n</em> atoms, number of atoms; <em>n</em>-ON acceptors, number of hydrogen bond acceptors; <em>n</em>-OHNH donors, number of hydrogen bonds donors; <em>n</em> rotb, number ofroutable bonds; <em>n</em> violations, number of violations; TPSA, topological polar surface area.</p>
</div></div></section><section class="tw xbox font-sm" id="tab2"><h4 class="obj_head">Table 2. Physicochemical Molinspiration bioactivity score.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1">Compound</th>
<th rowspan="1" colspan="1">GPCR ligand</th>
<th rowspan="1" colspan="1">Ion channel modulator</th>
<th rowspan="1" colspan="1">Kinase inhibitor</th>
<th rowspan="1" colspan="1">Nuclear receptor ligand</th>
<th rowspan="1" colspan="1">Protease inhibitor</th>
<th rowspan="1" colspan="1">Enzyme inhibitor</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">−0.35</td>
<td rowspan="1" colspan="1">−0.28</td>
<td rowspan="1" colspan="1">−0.53</td>
<td rowspan="1" colspan="1">−0.07</td>
<td rowspan="1" colspan="1">−0.31</td>
<td rowspan="1" colspan="1">−0.23</td>
</tr>
<tr>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">−0.21</td>
<td rowspan="1" colspan="1">−0.25</td>
<td rowspan="1" colspan="1">−0.39</td>
<td rowspan="1" colspan="1">−0.12</td>
<td rowspan="1" colspan="1">−0.30</td>
<td rowspan="1" colspan="1">−0.14</td>
</tr>
<tr>
<td rowspan="1" colspan="1">6</td>
<td rowspan="1" colspan="1">−0.31</td>
<td rowspan="1" colspan="1">−0.45</td>
<td rowspan="1" colspan="1">−0.70</td>
<td rowspan="1" colspan="1">−0.31</td>
<td rowspan="1" colspan="1">−0.47</td>
<td rowspan="1" colspan="1">−0.23</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec26"><h3 class="pmc_sec_title">ProTox-II tool</h3>
<p>ProtoxII virtual lab for the study of small molecule toxicity. Identifying chemical toxicity is an important stage in the development of novel medications. According to ProTox-II, the oral LD<sub>50</sub> values for the two compounds in a rat model vary from 690 to 1000 mg kg<sup>−1</sup>, with quercetin having the lowest value and (1s,4s)-Eucalyptol having the highest. <a href="#fig1" class="usa-link">Fig. 1</a> shows a comparison of chemicals 1 and 6 to those in the dataset.<sup><a href="#cit15" class="usa-link" aria-describedby="cit15">15</a></sup> Toxicology radar <a href="#fig1" class="usa-link">Fig. 1</a> is meant to immediately demonstrate the confidence of favorable toxicity data when compared to the average of its class for chemicals 1 and 6.</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Fig. 1. Displays the comparison of chemicals 1 and 6 to those in the dataset on the ProtoxII virtual lab.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/4c0b9f961afb/d5ra04955e-f1.jpg" loading="lazy" height="1785" width="774" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec27"><h3 class="pmc_sec_title">Molecular docking</h3>
<p>A molecular docking analysis was conducted using MOE (ver. 2022) to confirm the interaction between synthetic compounds and targets associated with anti-diabetic illness. All 7 targets associated with anti-diabetic illness were docked separately with each medication. These compounds have extraordinarily high binding affinities for all 7 anti-diabetic targets compared to the docked ligand [Acarbose and Evogliptin] as a reference for anti-diabetic evaluation using human pancreatic alpha-amylase in complex with mini-montbretin A (PDB ID: 5E0F). Two commercial drugs [Acarbose and Evogliptin] are powerful anti-diabetic drugs that inhibit 5E0F, as shown in <a href="#tab1" class="usa-link">Table 1</a>. Acarbose binds in a pocket dummy atom binding site, interacting with ASP 300 (A) and GLU 233 (A) with 3 hydrogen bonds and also establishing a pi-H with 5-ring TRP 59 (A), 6-ring TYR 62 (A), and 5-ring HIS 101 (A). While Evogliptin binds in a pocket dummy atom binding site, interacting with TYR 62 with pi-H. <a href="#fig2" class="usa-link">Fig. 2</a> depicts Acarbose and Evogliptin's binding location to 5E0F in 2D and 3D. All compounds, especially 1, 6, and 8, bind to the human pancreatic alpha-amylase in complex with mini-montbretin A (PDB ID: 5E0F) active site similarly to the native ligand, as shown in <a href="#tab1" class="usa-link">Table 1</a>. As depicted in <a href="#tab1" class="usa-link">Table 1</a>, target 1 was bound to the active site with docked scores of −6.047 (kcal mol<sup>−1</sup>). Whereas compound 6 exhibited the highest docking score of −6.6096 (kcal mol<sup>−1</sup>). Their re-docking poses were illustrated in <a href="#fig3" class="usa-link">Fig. 3</a>.</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">Fig. 2. 2D and 3D receptor interactions of the reference ligand [Acarbose and Evogliptin] and 5J7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/e12cca18dc9a/d5ra04955e-f2.jpg" loading="lazy" height="884" width="761" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">Fig. 3. 2D and 3D receptor interactions of the promising synthesized compounds.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/c667def3c1e1/d5ra04955e-f3.jpg" loading="lazy" height="1946" width="756" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>To validate the docking protocol, a redocking study was performed using the native ligand (5J7) present in the crystal structure of human pancreatic α-amylase (PDB ID: 5E0F). The ligand was extracted and re-docked into the active site under the same docking conditions used for the test compounds. The obtained RMSD value for the native ligand was 1.966 Å, which is within the generally accepted threshold of ≤ 2 Å, confirming the reliability of the docking parameters.</p>
<p>Further validation was performed by docking two commercially available and well-characterized α-amylase inhibitors, Acarbose and Evogliptin. These inhibitors were docked under identical conditions, and their binding scores (−8.399 kcal mol<sup>−1</sup> and −6.450 kcal mol<sup>−1</sup>, respectively), RMSD values (1.470 Å and 1.603 Å, respectively), and interaction profiles with key catalytic residues (Asp300, Glu233, Tyr62, Trp59, His101) were compared with those of the synthesized compounds. Several synthesized compounds, particularly compounds 1, 6, and 8, exhibited comparable or favorable binding affinities and similar binding modes to the reference ligands, interacting with the same critical residues in the active site (<a href="#tab3" class="usa-link">Table 3</a>).</p>
<section class="tw xbox font-sm" id="tab3"><h4 class="obj_head">Table 3. The binding scores, RMSD values, distance, and receptor interactions of the most promising compounds (1, 3, 5, 6, 7, 8, and 9) were compared to the docked ligand [Acarbose and Evogliptin] and 5J7 as a reference for anti-diabetic evaluation.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th rowspan="2" colspan="1">Comp</th>
<th rowspan="2" colspan="1">Score (kcal mol<sup>−1</sup>)</th>
<th rowspan="2" colspan="1">RMSD</th>
<th colspan="5" rowspan="1">Interacting residues</th>
</tr>
<tr>
<th rowspan="1" colspan="1">Ligand</th>
<th rowspan="1" colspan="1">Receptor</th>
<th rowspan="1" colspan="1">Interactions</th>
<th rowspan="1" colspan="1">Distance (Å)</th>
<th rowspan="1" colspan="1">
<em>E</em> (kcal mol<sup>−1</sup>)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3" colspan="1">5J7 (reference)</td>
<td rowspan="3" colspan="1">−9.04865932</td>
<td rowspan="3" align="center" colspan="1">1.966</td>
<td rowspan="1" colspan="1">O 28</td>
<td rowspan="1" colspan="1">ND1 HIS 305 (A)</td>
<td rowspan="1" colspan="1">H-acceptor</td>
<td align="center" rowspan="1" colspan="1">2.93</td>
<td align="center" rowspan="1" colspan="1">−2.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">O 62</td>
<td rowspan="1" colspan="1">OD1 ASP 300 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.85</td>
<td align="center" rowspan="1" colspan="1">−2.0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">C 75</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">3.41</td>
<td align="center" rowspan="1" colspan="1">−0.5</td>
</tr>
<tr>
<td rowspan="4" colspan="1">Acarbose</td>
<td rowspan="4" colspan="1">−8.39953136</td>
<td rowspan="4" align="center" colspan="1">1.470</td>
<td rowspan="1" colspan="1">O 81</td>
<td rowspan="1" colspan="1">OE1 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">3.27</td>
<td align="center" rowspan="1" colspan="1">−1.3</td>
</tr>
<tr>
<td rowspan="1" colspan="1">C 55</td>
<td rowspan="1" colspan="1">5-Ring TRP 59 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">3.92</td>
<td align="center" rowspan="1" colspan="1">−0.6</td>
</tr>
<tr>
<td rowspan="1" colspan="1">C 68</td>
<td rowspan="1" colspan="1">6-Ring TYR 62 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.49</td>
<td align="center" rowspan="1" colspan="1">−0.7</td>
</tr>
<tr>
<td rowspan="1" colspan="1">O 86</td>
<td rowspan="1" colspan="1">5-Ring HIS 101 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.24</td>
<td align="center" rowspan="1" colspan="1">−1.0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Evogliptin</td>
<td rowspan="1" colspan="1">−6.45007515</td>
<td align="center" rowspan="1" colspan="1">1.603</td>
<td rowspan="1" colspan="1">C 36</td>
<td rowspan="1" colspan="1">6-Ring TYR 62 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.24</td>
<td align="center" rowspan="1" colspan="1">−1.0</td>
</tr>
<tr>
<td rowspan="2" colspan="1">1</td>
<td rowspan="2" colspan="1">−6.04776144</td>
<td rowspan="2" align="center" colspan="1">1.365</td>
<td rowspan="1" colspan="1">O 11</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.70</td>
<td align="center" rowspan="1" colspan="1">−1.7</td>
</tr>
<tr>
<td rowspan="1" colspan="1">N 5</td>
<td rowspan="1" colspan="1">6-Ring TYR 62 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">3.85</td>
<td align="center" rowspan="1" colspan="1">−0.8</td>
</tr>
<tr>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">−5.58074379</td>
<td align="center" rowspan="1" colspan="1">0.529</td>
<td rowspan="1" colspan="1">N 35</td>
<td rowspan="1" colspan="1">6-Ring TYR 62 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.20</td>
<td align="center" rowspan="1" colspan="1">−1.8</td>
</tr>
<tr>
<td rowspan="3" colspan="1">5</td>
<td rowspan="3" colspan="1">−5.26979733</td>
<td rowspan="3" align="center" colspan="1">1.554</td>
<td rowspan="1" colspan="1">N 11</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.98</td>
<td align="center" rowspan="1" colspan="1">−4.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">N 33</td>
<td rowspan="1" colspan="1">OG1 THR 163 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">3.04</td>
<td align="center" rowspan="1" colspan="1">−1.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">N 16</td>
<td rowspan="1" colspan="1">NE2 HIS 299 (A)</td>
<td rowspan="1" colspan="1">H-acceptor</td>
<td align="center" rowspan="1" colspan="1">3.63</td>
<td align="center" rowspan="1" colspan="1">−1.0</td>
</tr>
<tr>
<td rowspan="2" colspan="1">6</td>
<td rowspan="2" colspan="1">−6.6096797</td>
<td rowspan="2" align="center" colspan="1">1.217</td>
<td rowspan="1" colspan="1">N 59</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.99</td>
<td align="center" rowspan="1" colspan="1">−3.4</td>
</tr>
<tr>
<td rowspan="1" colspan="1">C 49</td>
<td rowspan="1" colspan="1">5-Ring TRP 59 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.23</td>
<td align="center" rowspan="1" colspan="1">−0.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">−5.78755617</td>
<td align="center" rowspan="1" colspan="1">1.989</td>
<td rowspan="1" colspan="1">N 43</td>
<td rowspan="1" colspan="1">OE1 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.97</td>
<td align="center" rowspan="1" colspan="1">−3.9</td>
</tr>
<tr>
<td rowspan="3" colspan="1">8</td>
<td rowspan="3" colspan="1">−5.62768507</td>
<td rowspan="3" align="center" colspan="1">1.188</td>
<td rowspan="1" colspan="1">N 13</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.90</td>
<td align="center" rowspan="1" colspan="1">−8.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">O 30</td>
<td rowspan="1" colspan="1">NH2 ARG 195 (A)</td>
<td rowspan="1" colspan="1">H-acceptor</td>
<td align="center" rowspan="1" colspan="1">2.99</td>
<td align="center" rowspan="1" colspan="1">−2.4</td>
</tr>
<tr>
<td rowspan="1" colspan="1">N 16</td>
<td rowspan="1" colspan="1">6-Ring TYR 62 (A)</td>
<td rowspan="1" colspan="1">H-pi</td>
<td align="center" rowspan="1" colspan="1">4.20</td>
<td align="center" rowspan="1" colspan="1">−0.8</td>
</tr>
<tr>
<td rowspan="1" colspan="1">9</td>
<td rowspan="1" colspan="1">−5.00731277</td>
<td align="center" rowspan="1" colspan="1">0.991</td>
<td rowspan="1" colspan="1">N 23</td>
<td rowspan="1" colspan="1">OE2 GLU 233 (A)</td>
<td rowspan="1" colspan="1">H-donor</td>
<td align="center" rowspan="1" colspan="1">2.88</td>
<td align="center" rowspan="1" colspan="1">−8.8</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>These validation steps redocking of the native ligand and comparison with known inhibitors confirm that the docking protocol is robust and the <em>in silico</em> results are credible.</p></section><section id="sec28"><h3 class="pmc_sec_title">Optimization of radiochemical yield for 131-iodocomp 1</h3>
<p>To enhance the radiolabeling efficiency of 131-iodocomp 1, the experimental conditions were systematically adjusted, including the concentrations of comp 1 and CH-T, as well as the pH, reaction duration, and temperature (<a href="#fig4" class="usa-link">Fig. 4</a>). The highest radiochemical yield (RCY) achieved was 94.3 ± 1.1%, as measured by paper chromatography. This optimal result was obtained when the reaction used 200 μg ml<sup>−1</sup> of comp. 1 and 100 μg of ChT, conducted at pH 4 for 30 minutes at room temperature (25 °C), <a href="#fig4" class="usa-link">Fig. 4</a>.</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">Fig. 4. Optimization of Radiochemical Yield for 131-iodocomp 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/be45fee8f5c9/d5ra04955e-f4.jpg" loading="lazy" height="508" width="779" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec29"><h3 class="pmc_sec_title">Bio-evaluation</h3>
<section id="sec30"><h4 class="pmc_sec_title">
<em>In vitro</em> α-Amylase biological evaluation</h4>
<p>The α-amylase inhibition activity was estimated for compounds 1, 6, and 8, with acarbose as the standard. In <a href="#fig5" class="usa-link">Fig. 5</a>, all tested compounds showed inhibitory potential to different degrees. Compound 1 exhibited the highest inhibiting activity, with an IC<sub>50</sub> of 34.60 ± 1.43 μg ml<sup>−1</sup>. This result agrees with the compound's structural characteristics, forming favorable binding site activity of α-amylase, as the <em>in silico</em> findings show.</p>
<figure class="fig xbox font-sm" id="fig5"><h5 class="obj_head">Fig. 5. Elucidate the amylase inhibitory effects of compounds 1, 6, 8, and standard acarbose, respectively, showing the superiority of compound 1 (IC<sub>50</sub> = 34.60 ± 1.43 μg ml<sup>−1</sup>) relative to compounds 6 and 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/dab862582abf/d5ra04955e-f5.jpg" loading="lazy" height="490" width="761" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Our pyrimidine scaffold (<em>e.g.</em>, Compound 1) offers distinct advantages over recent pyrimidine-based α-amylase inhibitors:</p>
<p>Our pyrimidine scaffold exhibits a distinctive structural profile and functional versatility compared to previously reported pyrimidine-based α-amylase inhibitors. Unlike the thiazolopyrimidine carboxylates reported by Batool <em>et al.</em> (2016),<sup><a href="#cit50" class="usa-link" aria-describedby="cit50">50</a></sup> which lack dual polar substituents, our design integrates both acetyl and hydroxyl moieties, enabling enhanced hydrogen bonding with Glu233 and Tyr62 in the α-amylase active site (docking score −6.05 kcal mol<sup>−1</sup><em>vs.</em> −5.29 kcal mol<sup>−1</sup>). Moreover, the dual theranostic potential combining α-amylase inhibition with radiolabeling for imaging represents a rare approach, as prior works such as Chigurupati <em>et al.</em> (2021) focused solely on enzymatic inhibition.<sup><a href="#cit20" class="usa-link" aria-describedby="cit20">20</a></sup> The TiO<sub>2</sub>-nanocatalyzed synthesis also achieved a significantly higher yield (98% in 6 h) compared to conventional protocols (<em>e.g.</em>, 58% in 15 h, Hassaballah <em>et al.</em>, 2024), underscoring its green and efficient nature.<sup><a href="#cit51" class="usa-link" aria-describedby="cit51">51</a></sup></p></section><section id="sec31"><h4 class="pmc_sec_title">
<em>In Vivo</em> biodistribution study</h4>
<p>The <em>in vivo</em> behavior of the highest amylase inhibitor compound 1 was studied using [<sup>131</sup>I]-labeled mice. Radioactivity levels were measured in major organs at different time points (1 to 36 hours post-injection), and results were expressed as % injected dose per gram of tissue, <a href="#fig6" class="usa-link">Fig. 6</a>. Following administration, a marked initial accumulation was seen in the stomach (59.58% ID per g) and intestine (11.70% ID per g) at the 1 hour post-injection. Gastric levels decreased slowly, while intestinal uptake increased, reaching a maximum at 16 hours (34.93% ID per g). This distribution profile is indicative of gastrointestinal slow release, which is potentially attributed to the compound's α-amylase affinity and possibly species differences in gastric retention in mice. These findings are comparable with compounds that block carbohydrate digestion enzymes, such as acarbose, and may indicate slow intestinal clearance (enterohepatic circulation) or mucosal interaction.<sup><a href="#cit52" class="usa-link" aria-describedby="cit52">52</a></sup> The stable blood levels from 12.13% ID per g at 1 hour to 8.72% ID per g at 36 hours indicate evidence of low systemic clearance, possibly enhancing the compound's availability for therapeutic action through re-excretion to the intestine. There was a continuous increase in muscle uptake with time, reaching 20.15% ID per g at 36 hours, indicating progressive peripheral uptake. This muscle uptake retention highlights a potential link to muscle-related side effects (<em>e.g.</em>, weakness, fatigue) reported with acarbose, though the mechanism is unclear. It is possible that amylase-binding-related compounds like this may be retained in muscle tissue, either through passive diffusion or transport mechanisms related to glucose metabolism or unknown mechanisms.<sup><a href="#cit53" class="usa-link" aria-describedby="cit53">53</a></sup> Liver uptake reaches maximum at 8 hours, indicating early hepatic metabolism. This uptake is similar for compounds showing phase I/II metabolism. Kidney uptake increased continuously, indicating some renal clearance as a possible primary elimination route. The slow increase in thyroid uptake (2.38% ID per g at 36 h), bone, and spleen radioactivity may highlight <em>in vivo</em> deiodination, a known equilibrium of radioiodinated tracers, leading to radio uptake of free [<sup>131</sup>I] in iodine-avid tissues. Such deiodination limits imaging specificity but could be minimized by modifying the compound to resist enzymatic degradation or by using alternative radionuclides with greater <em>in vivo</em> stability.<sup><a href="#cit54" class="usa-link" aria-describedby="cit54">54</a></sup> Accordingly, Compound 1 demonstrated the highest α-amylase inhibition <em>in vitro</em> and a favorable biodistribution profile, particularly with regard to prolonged intestinal residence. The slow gastric clearance and prominent intestinal and muscle uptake highlight its potential as a gastrointestinal-targeted antidiabetic agent, as well as a radiotracer for GI imaging probes. The continuous muscle accumulation observed may give a new glimpse of the muscle-related side effects that were found with amylase inhibitors. Further studies are needed to find out the mechanisms attributed to side effects and to explore the clinical perspective of this compound as both a therapeutic and diagnostic agent.</p>
<figure class="fig xbox font-sm" id="fig6"><h5 class="obj_head">Fig. 6. elucidates the organs uptake as % injected dose/organ tissue at different times was expressed as X±S.E.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12376908_d5ra04955e-f6.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba3/12376908/50a3c461d0b0/d5ra04955e-f6.jpg" loading="lazy" height="486" width="734" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The <em>in vivo</em> biodistribution profile of <sup>131</sup>I–Compound 1 demonstrated marked gastrointestinal (GIT) specificity and stability when compared with control data. Free <sup>131</sup>I is known to accumulate predominantly in the thyroid due to iodide trapping; however, <sup>131</sup>I–Compound 1 exhibited minimal thyroid uptake (&lt;3% ID per g), confirming <em>in vivo</em> stability and reduced deiodination.<sup><a href="#cit55" class="usa-link" aria-describedby="cit55">55</a></sup> Notably, stomach retention was significantly higher (59.58 ± 3.2% ID per g at 1 h) than literature-reported values for the α-amylase inhibitor acarbose (∼15% ID per g at 4 h).<sup><a href="#cit52" class="usa-link" aria-describedby="cit52">52</a></sup> Sustained intestinal accumulation (34.93% ID per g at 16 h) was approximately threefold greater than in muscle, indicating selective GIT targeting. This slow intestinal clearance aligns with prolonged luminal α-amylase inhibition, which is advantageous for maintaining therapeutic concentrations at the primary enzymatic site while minimizing systemic exposure.</p>
<p>The pronounced accumulation of the radiolabeled pyrimidine derivative in the stomach (59.58% ID per g) and intestine (34.93% ID per g) is consistent with the luminal localization of α-amylase, a digestive enzyme predominantly secreted into the gastrointestinal tract.<sup><a href="#cit21" class="usa-link" aria-describedby="cit21">21</a></sup> This preferential uptake suggests that the compound can achieve high local concentrations at the primary site of enzymatic activity, potentially enhancing inhibitory efficacy while minimizing systemic exposure. Such targeted distribution supports its theranostic potential, enabling simultaneous enzyme inhibition and imaging within the gastrointestinal environment.</p></section></section></section><section id="sec32"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The findings of this study demonstrate the successful development of a pyrimidine-based compound with dual therapeutic and diagnostic potential for diabetes management. Several synthesized derivatives exhibited strong <em>in silico</em> binding affinities toward α-amylase, with compound 1 emerging as the most promising candidate. Guided by molecular docking and <em>in vitro</em> enzyme inhibition assays, compound 1 was radiolabeled with iodine-131, and key parameters, including ligand concentration, pH, and reaction time, were optimized to achieve high radiochemical yield and stability. Notably, compound 1 displayed both potent α-amylase inhibitory activity and a favorable pharmacokinetic profile. Its high accumulation in the gastrointestinal tract underscores its potential role in regulating postprandial glucose levels. Moreover, its gradual uptake in muscle tissue suggests possible systemic effects that may provide insight into muscle-related outcomes associated with α-amylase inhibitors. The compound's stable radiolabeling and prolonged tissue retention further support its utility as a potential molecular imaging agent for gastrointestinal applications, alongside its therapeutic promise. Nevertheless, additional studies are warranted to refine its molecular structure, improve specificity, and minimize off-target distribution.</p></section><section id="sec33"><h2 class="pmc_sec_title">Ethical statement</h2>
<p>All animal procedures were performed in accordance with the CIOMS and ICLAS International Guiding Principles for Biomedical Research Involving Animals (2012) and approved by the Research Ethics Committee of the National Center for Radiation Research and Technology (REC-NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt (Protocol No.: P/99A/24).</p></section><section id="sec34"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Doaa A. Elsayed: Writing – review, editing, methodology, investigation, formal analysis, data curation, editing computational study &amp; conceptualization. Wael Shehta: Writing—review, editing, methodology, investigation, formal analysis, data curation &amp; conceptualization. S. El-Kalyoubi: Writing—review, editing, methodology, investigation, formal analysis, data curation &amp; conceptualization. Adli Selim: Writing – review, editing, methodology, investigation, formal analysis, data curation &amp; conceptualization for biology, and optimization of radiochemical yield for 131-iodo. Mohamed G. Assy: Visualization, supervision, project administration, investigation, formal analysis, data curation &amp; conceptualization. Omar Metwally: Writing—review, editing, methodology, investigation, formal analysis, data curation &amp; conceptualization. Ahmed A. Al-Kubaisi: Writing—review &amp; funding acquisition. Sameer A. Awad: Writing—review &amp; funding acquisition. F, Marzook: Writing – review, editing, methodology, investigation, formal analysis, data curation &amp; conceptualization for biology, and optimization of radiochemical yield for 131-iodo.</p></section><section id="sec35"><h2 class="pmc_sec_title">Conflicts of interest</h2>
<p>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></section><section id="sec36"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="RA-015-D5RA04955E-s001"><div class="caption p"><span>RA-015-D5RA04955E-s001</span></div>
<div class="media p" id="d67e2041"><div class="caption">
<a href="/articles/instance/12376908/bin/RA-015-D5RA04955E-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">RA-015-D5RA04955E-s001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors express their sincere gratitude to Zagazig University, the Science faculty, and the Chemistry department.</p></section><section id="sec37"><h2 class="pmc_sec_title">Data availability</h2>
<p>The data supporting this article have been included as part of the SI.</p>
<p>The SI includes detailed experimental procedures, full characterization data of the synthesized compounds (<sup>1</sup>H NMR, <sup>13</sup>C NMR, IR spectra). See DOI: <a href="https://doi.org/10.1039/d5ra04955e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1039/d5ra04955e</a>.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="cit1">
<cite>Zhu H. Luo P. Fu Y. Wang J. Dai J. Shao J. 
et al., Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin. Oncotarget. 2015;6(5):3254. doi: 10.18632/oncotarget.2410.</cite> [<a href="https://doi.org/10.18632/oncotarget.2410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4413651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25226612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=et%20al.,%20Dihydromyricetin%20prevents%20cardiotoxicity%20and%20enhances%20anticancer%20activity%20induced%20by%20adriamycin&amp;author=H.%20Zhu&amp;author=P.%20Luo&amp;author=Y.%20Fu&amp;author=J.%20Wang&amp;author=J.%20Dai&amp;volume=6&amp;issue=5&amp;publication_year=2015&amp;pages=3254&amp;pmid=25226612&amp;doi=10.18632/oncotarget.2410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit2">
<cite>Abro A. Kulsoom S. Riaz N. Pharmacophore model generation for microtubule-stabilizing anti-mitotic agents (MSAAs) against ovarian cancer. Med. Chem. Res. 2013;22:4322–4330.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Chem.%20Res.&amp;title=Pharmacophore%20model%20generation%20for%20microtubule-stabilizing%20anti-mitotic%20agents%20(MSAAs)%20against%20ovarian%20cancer&amp;author=A.%20Abro&amp;author=S.%20Kulsoom&amp;author=N.%20Riaz&amp;volume=22&amp;publication_year=2013&amp;pages=4322-4330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit3">
<cite>Ahmed O. Hussein A. Ahmed R. Antidiabetic and antioxidant effects of newly synthesized pyrimido [1, 6-a] pyrimidine derivatives in neonatal streptozotocin-induced diabetic Rats. Med. Chem. 2012;2(1):20–28.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Chem.&amp;title=Antidiabetic%20and%20antioxidant%20effects%20of%20newly%20synthesized%20pyrimido%20%5B1,%206-a%5D%20pyrimidine%20derivatives%20in%20neonatal%20streptozotocin-induced%20diabetic%20Rats&amp;author=O.%20Ahmed&amp;author=A.%20Hussein&amp;author=R.%20Ahmed&amp;volume=2&amp;issue=1&amp;publication_year=2012&amp;pages=20-28&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit4">
<cite>Akhtar N. Jafri L. Green B. D. Kalsoom S. Mirza B. A multi-mode bioactive agent isolated from Ficus microcarpa L. Fill. with therapeutic potential for type 2 diabetes mellitus. Front. Pharmacol. 2018;9:1376. doi: 10.3389/fphar.2018.01376.</cite> [<a href="https://doi.org/10.3389/fphar.2018.01376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6277780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30542284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol&amp;title=A%20multi-mode%20bioactive%20agent%20isolated%20from%20Ficus%20microcarpa%20L.%20Fill.%20with%20therapeutic%20potential%20for%20type%202%20diabetes%20mellitus&amp;author=N.%20Akhtar&amp;author=L.%20Jafri&amp;author=B.%20D.%20Green&amp;author=S.%20Kalsoom&amp;author=B.%20Mirza&amp;volume=9&amp;publication_year=2018&amp;pages=1376&amp;pmid=30542284&amp;doi=10.3389/fphar.2018.01376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit5">
<cite>Anupama B. Dinda S. C. Prasad Y. R. Rao A. V. Synthesis and antimicrobial activity of some new 2, 4, 6-trisubstituted pyrimidines. Int. J. Res. Pharm. Chem. 2012;2(2):231–236.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Res.%20Pharm.%20Chem.&amp;title=Synthesis%20and%20antimicrobial%20activity%20of%20some%20new%202,%204,%206-trisubstituted%20pyrimidines&amp;author=B.%20Anupama&amp;author=S.%20C.%20Dinda&amp;author=Y.%20R.%20Prasad&amp;author=A.%20V.%20Rao&amp;volume=2&amp;issue=2&amp;publication_year=2012&amp;pages=231-236&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit6">
<cite>Batool I. Saeed A. Qureshi I. Z. Kalsoom S. Razzaq A. Synthesis, molecular docking and biological evaluation of new thiazolopyrimidine carboxylates as potential antidiabetic and antibacterial agents. Res. Chem. Intermed. 2016;42:1139–1163.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Chem.%20Intermed.&amp;title=Synthesis,%20molecular%20docking%20and%20biological%20evaluation%20of%20new%20thiazolopyrimidine%20carboxylates%20as%20potential%20antidiabetic%20and%20antibacterial%20agents&amp;author=I.%20Batool&amp;author=A.%20Saeed&amp;author=I.%20Z.%20Qureshi&amp;author=S.%20Kalsoom&amp;author=A.%20Razzaq&amp;volume=42&amp;publication_year=2016&amp;pages=1139-1163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit7">
<cite>Davies M. J. D'Alessio D. A. Fradkin J. Kernan W. N. Mathieu C. Mingrone G. 
et al., Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2018;41(12):2669–2701. doi: 10.2337/dci18-0033.</cite> [<a href="https://doi.org/10.2337/dci18-0033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6245208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30291106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=et%20al.,%20Management%20of%20hyperglycemia%20in%20type%202%20diabetes,%202018.%20A%20consensus%20report%20by%20the%20American%20Diabetes%20Association%20(ADA)%20and%20the%20European%20Association%20for%20the%20Study%20of%20Diabetes%20(EASD)&amp;author=M.%20J.%20Davies&amp;author=D.%20A.%20D'Alessio&amp;author=J.%20Fradkin&amp;author=W.%20N.%20Kernan&amp;author=C.%20Mathieu&amp;volume=41&amp;issue=12&amp;publication_year=2018&amp;pages=2669-2701&amp;pmid=30291106&amp;doi=10.2337/dci18-0033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit8">
<cite>Khalid T. Kalsooom S. Anwar S. Farrukh A. Gao L. Jafri L. Molecular Docking, Synthesis and Anti-diabetic Studies of Pyrimidine Derivatives. Ann. Pharmacolog. Pharm. 2024;9(1):1211.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Pharmacolog.%20Pharm.&amp;title=Molecular%20Docking,%20Synthesis%20and%20Anti-diabetic%20Studies%20of%20Pyrimidine%20Derivatives&amp;author=T%20Khalid&amp;author=S%20Kalsooom&amp;author=S%20Anwar&amp;author=A%20Farrukh&amp;author=L%20Gao&amp;volume=9&amp;issue=1&amp;publication_year=2024&amp;pages=1211&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit9">
<cite>
Elsayed D. A., Shehab W. and Haikal H., Design, synthesis, and computational studies as cytotoxicity of novel pyrimidine carbonitrile derivatives as dual-target inhibitors of BRD4, Bulletin of Faculty of Science, Zagazig University, 2025, vol. 2025, (1), pp. 141–52</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Bulletin%20of%20Faculty%20of%20Science&amp;author=D.%20A.%20Elsayed&amp;author=W.%20Shehab&amp;author=H.%20Haikal&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit10">
<cite>
Shehab W., Computational Chemistry for some Novel Pyrimidine derivatives as Significant Antioxidants using cytochrome c peroxidase enzyme, Bulletin of Faculty of Science, Zagazig University, 2025, vol. 2025, (1), pp. 171–7</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Bulletin%20of%20Faculty%20of%20Science&amp;author=W.%20Shehab&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit11">
<cite>Elsayed D. A. Abdu M. E. Marzouk M. A. Mahmoud E. M. El-Shwiniy W. H. Spring A. M. 
et al., Bio-computational modeling, POM analysis and molecular dynamic simulation for novel synthetic quinolone and benzo [d][1, 3] oxazine candidates as antimicrobial inhibitors. Sci. Rep. 2024;14(1):28709. doi: 10.1038/s41598-024-73972-x.</cite> [<a href="https://doi.org/10.1038/s41598-024-73972-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11579483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39567581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=et%20al.,%20Bio-computational%20modeling,%20POM%20analysis%20and%20molecular%20dynamic%20simulation%20for%20novel%20synthetic%20quinolone%20and%20benzo%20%5Bd%5D%5B1,%203%5D%20oxazine%20candidates%20as%20antimicrobial%20inhibitors&amp;author=D.%20A.%20Elsayed&amp;author=M.%20E.%20Abdu&amp;author=M.%20A.%20Marzouk&amp;author=E.%20M.%20Mahmoud&amp;author=W.%20H.%20El-Shwiniy&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=28709&amp;pmid=39567581&amp;doi=10.1038/s41598-024-73972-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit12"><cite>
Elsayed D. A., Abd-ElSattar A., Abdu M. E. and Shehab W. S., A Concise Review of Nanocomposites’ Function in Organic Reactions to Synthesize Various Organic Nuclei, International Exchange and Innovation Conference on Engineering &amp; Sciences, 2024</cite></li>
<li id="cit13">
<cite>Das K. Iyer K. R. Orfali R. Asdaq S. M. B. Alotaibi N. S. Alotaibi F. S. 
et al., In silico studies and evaluation of in vitro antidiabetic activity of berberine from ethanol seed extract of Coscinium fenestratum (Gaertn.) Colebr. J. King Saud Univ., Sci. 2023;35(5):102666.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20King%20Saud%20Univ.,%20Sci.&amp;title=et%20al.,%20In%20silico%20studies%20and%20evaluation%20of%20in%20vitro%20antidiabetic%20activity%20of%20berberine%20from%20ethanol%20seed%20extract%20of%20Coscinium%20fenestratum%20(Gaertn.)%20Colebr&amp;author=K.%20Das&amp;author=K.%20R.%20Iyer&amp;author=R.%20Orfali&amp;author=S.%20M.%20B.%20Asdaq&amp;author=N.%20S.%20Alotaibi&amp;volume=35&amp;issue=5&amp;publication_year=2023&amp;pages=102666&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit14">
<cite>Thao T. T. P. Bui T. Q. Quy P. T. Bao N. C. Van Loc T. Van Chien T. 
et al., Isolation, semi-synthesis, docking-based prediction, and bioassay-based activity of Dolichandrone spathacea iridoids: new catalpol derivatives as glucosidase inhibitors. RSC Adv. 2021;11(20):11959–11975. doi: 10.1039/d1ra00441g.</cite> [<a href="https://doi.org/10.1039/d1ra00441g" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8696980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35423771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Adv.&amp;title=et%20al.,%20Isolation,%20semi-synthesis,%20docking-based%20prediction,%20and%20bioassay-based%20activity%20of%20Dolichandrone%20spathacea%20iridoids:%20new%20catalpol%20derivatives%20as%20glucosidase%20inhibitors&amp;author=T.%20T.%20P.%20Thao&amp;author=T.%20Q.%20Bui&amp;author=P.%20T.%20Quy&amp;author=N.%20C.%20Bao&amp;author=T.%20Van%20Loc&amp;volume=11&amp;issue=20&amp;publication_year=2021&amp;pages=11959-11975&amp;pmid=35423771&amp;doi=10.1039/d1ra00441g&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit15">
<cite>Shehab W. S. Elsayed D. A. Abdel Hamid A. M. Assy M. G. Mouneir S. M. Hamed E. O. 
et al., CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies. Sci. Rep. 2024;14(1):1608. doi: 10.1038/s41598-024-51708-1.</cite> [<a href="https://doi.org/10.1038/s41598-024-51708-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10796945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38238369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=et%20al.,%20CuO%20nanoparticles%20for%20green%20synthesis%20of%20significant%20anti-Helicobacter%20pylori%20compounds%20with%20in%20silico%20studies&amp;author=W.%20S.%20Shehab&amp;author=D.%20A.%20Elsayed&amp;author=A.%20M.%20Abdel%20Hamid&amp;author=M.%20G.%20Assy&amp;author=S.%20M.%20Mouneir&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=1608&amp;pmid=38238369&amp;doi=10.1038/s41598-024-51708-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit16">
<cite>Shehab W. S. Haikal H. A. Elsayed D. A. El-Farargy A. F. El-Gazzar A.-R. B. El-Bassyouni G. T. 
et al., Pharmacokinetic and molecular docking studies to pyrimidine drug using Mn3O4 nanoparticles to explore potential anti-Alzheimer activity. Sci. Rep. 2024;14(1):15436. doi: 10.1038/s41598-024-65166-2.</cite> [<a href="https://doi.org/10.1038/s41598-024-65166-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11224222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38965280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=et%20al.,%20Pharmacokinetic%20and%20molecular%20docking%20studies%20to%20pyrimidine%20drug%20using%20Mn3O4%20nanoparticles%20to%20explore%20potential%20anti-Alzheimer%20activity&amp;author=W.%20S.%20Shehab&amp;author=H.%20A.%20Haikal&amp;author=D.%20A.%20Elsayed&amp;author=A.%20F.%20El-Farargy&amp;author=A.-R.%20B.%20El-Gazzar&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=15436&amp;pmid=38965280&amp;doi=10.1038/s41598-024-65166-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit17">
<cite>
Elsayed D. A.. Design, synthesis, biological evaluation, and molecular docking studies of novel azo-compounds derivatives as significant antioxidants. Bulletin of Faculty of Science, Zagazig University, 2023, vol. 2023, (1), pp. 1–9</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Bulletin%20of%20Faculty%20of%20Science&amp;author=D.%20A.%20Elsayed&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit18">
<cite>Shehab W. S. Magdy N. Elhoseni M. A. Assy M. G. AbdEl-Azim M. H. Mesbah A. E. 
et al., Design, synthesis and characterization of new fused pyrazole systems: In Vitro anti-bacterial, anti-fungal, antioxidant evaluation, In Silico DFT and molecular docking studies. J. Mol. Struct. 2025;1337:142163.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=et%20al.,%20Design,%20synthesis%20and%20characterization%20of%20new%20fused%20pyrazole%20systems:%20In%20Vitro%20anti-bacterial,%20anti-fungal,%20antioxidant%20evaluation,%20In%20Silico%20DFT%20and%20molecular%20docking%20studies&amp;author=W.%20S.%20Shehab&amp;author=N.%20Magdy&amp;author=M.%20A.%20Elhoseni&amp;author=M.%20G.%20Assy&amp;author=M.%20H.%20AbdEl-Azim&amp;volume=1337&amp;publication_year=2025&amp;pages=142163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit19">
<cite>Elsayed D. A. Eco-friendly synthesis, docking study, pharmacokinetics studies, and anti-proliferative evaluation of pyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors. Egypt. J. Chem. 2025 doi: 10.21608/ejchem.2025.357210.11244.</cite> [<a href="https://doi.org/10.21608/ejchem.2025.357210.11244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Egypt.%20J.%20Chem.&amp;title=Eco-friendly%20synthesis,%20docking%20study,%20pharmacokinetics%20studies,%20and%20anti-proliferative%20evaluation%20of%20pyrimidine%20derivatives%20as%20dual%20Topoisomerase%20II%20and%20HSP90%20inhibitors&amp;author=D.%20A.%20Elsayed&amp;publication_year=2025&amp;doi=10.21608/ejchem.2025.357210.11244&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit20">
<cite>Chigurupati S. Alharbi F. S. Almahmoud S. Aldubayan M. Almoshari Y. Vijayabalan S. 
et al., Molecular docking of phenolic compounds and screening of antioxidant and antidiabetic potential of Olea europaea L. Ethanolic leaves extract. Arabian J. Chem. 2021;14(11):103422.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Arabian%20J.%20Chem.&amp;title=et%20al.,%20Molecular%20docking%20of%20phenolic%20compounds%20and%20screening%20of%20antioxidant%20and%20antidiabetic%20potential%20of%20Olea%20europaea%20L.%20Ethanolic%20leaves%20extract&amp;author=S.%20Chigurupati&amp;author=F.%20S.%20Alharbi&amp;author=S.%20Almahmoud&amp;author=M.%20Aldubayan&amp;author=Y.%20Almoshari&amp;volume=14&amp;issue=11&amp;publication_year=2021&amp;pages=103422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit21">
<cite>Nyambe-Silavwe H. Villa-Rodriguez J. A. Ifie I. Holmes M. Aydin E. Jensen J. M. 
et al., Inhibition of human α-amylase by dietary polyphenols. J. Funct. Foods. 2015;19:723–732.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Funct.%20Foods&amp;title=et%20al.,%20Inhibition%20of%20human%20%CE%B1-amylase%20by%20dietary%20polyphenols&amp;author=H.%20Nyambe-Silavwe&amp;author=J.%20A.%20Villa-Rodriguez&amp;author=I.%20Ifie&amp;author=M.%20Holmes&amp;author=E.%20Aydin&amp;volume=19&amp;publication_year=2015&amp;pages=723-732&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit22">
<cite>Sanad M. Marzook F. Rizvi S. Farag A. Fouzy A. Radioiodinated azilsartan as a new highly selective radiotracer for myocardial perfusion imaging. Radiochemistry. 2021;63:520–525.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochemistry&amp;title=Radioiodinated%20azilsartan%20as%20a%20new%20highly%20selective%20radiotracer%20for%20myocardial%20perfusion%20imaging&amp;author=M.%20Sanad&amp;author=F.%20Marzook&amp;author=S.%20Rizvi&amp;author=A.%20Farag&amp;author=A.%20Fouzy&amp;volume=63&amp;publication_year=2021&amp;pages=520-525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit23">
<cite>Sanad M. Eyssa H. Marzook F. Farag A. Rizvi S. Mandal S. K. 
et al., Radiosynthesis and Biological Evaluation of 99m Tc Nitrido-Levetiracetam as a Brain Imaging Agent. Radiochemistry. 2021;63:635–641.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochemistry&amp;title=et%20al.,%20Radiosynthesis%20and%20Biological%20Evaluation%20of%2099m%20Tc%20Nitrido-Levetiracetam%20as%20a%20Brain%20Imaging%20Agent&amp;author=M.%20Sanad&amp;author=H.%20Eyssa&amp;author=F.%20Marzook&amp;author=A.%20Farag&amp;author=S.%20Rizvi&amp;volume=63&amp;publication_year=2021&amp;pages=635-641&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit24">
<cite>Sanad M. Farag A. B. Marzook F. Mandal S. K. Preparation, characterization, and bioevaluation of 99mTc-famotidine as a selective radiotracer for peptic ulcer disorder detection in mice. Radiochim. Acta. 2022;110(1):67–74.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochim.%20Acta&amp;title=Preparation,%20characterization,%20and%20bioevaluation%20of%2099mTc-famotidine%20as%20a%20selective%20radiotracer%20for%20peptic%20ulcer%20disorder%20detection%20in%20mice&amp;author=M.%20Sanad&amp;author=A.%20B.%20Farag&amp;author=F.%20Marzook&amp;author=S.%20K.%20Mandal&amp;volume=110&amp;issue=1&amp;publication_year=2022&amp;pages=67-74&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit25">
<cite>Sanad M. Farag A. Bassem S. A. Marzook F. Radioiodination of zearalenone and determination of Lactobacillus plantarum effect of on zearalenone organ distribution: In silico study and preclinical evaluation. Toxicol Rep. 2022;9:470–479. doi: 10.1016/j.toxrep.2022.02.003.</cite> [<a href="https://doi.org/10.1016/j.toxrep.2022.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8956894/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35345860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20Rep&amp;title=Radioiodination%20of%20zearalenone%20and%20determination%20of%20Lactobacillus%20plantarum%20effect%20of%20on%20zearalenone%20organ%20distribution:%20In%20silico%20study%20and%20preclinical%20evaluation&amp;author=M.%20Sanad&amp;author=A.%20Farag&amp;author=S.%20A.%20Bassem&amp;author=F.%20Marzook&amp;volume=9&amp;publication_year=2022&amp;pages=470-479&amp;pmid=35345860&amp;doi=10.1016/j.toxrep.2022.02.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit26">
<cite>Sanad M. Eyssa H. Marzook F. Rizvi S. Farag A. Fouzy A. 
et al., Synthesis, radiolabeling, and biological evaluation of 99mTc-Tricarbonyl mesalamine as a potential ulcerative colitis imaging agent. Radiochemistry. 2021;63(6):835–842.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochemistry&amp;title=et%20al.,%20Synthesis,%20radiolabeling,%20and%20biological%20evaluation%20of%2099mTc-Tricarbonyl%20mesalamine%20as%20a%20potential%20ulcerative%20colitis%20imaging%20agent&amp;author=M.%20Sanad&amp;author=H.%20Eyssa&amp;author=F.%20Marzook&amp;author=S.%20Rizvi&amp;author=A.%20Farag&amp;volume=63&amp;issue=6&amp;publication_year=2021&amp;pages=835-842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit27">
<cite>Lipinski C. A. Lombardo F. Dominy B. W. Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997;23(1–3):3–25. doi: 10.1016/s0169-409x(00)00129-0.</cite> [<a href="https://doi.org/10.1016/s0169-409x(00)00129-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11259830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Drug%20Delivery%20Rev.&amp;title=Experimental%20and%20computational%20approaches%20to%20estimate%20solubility%20and%20permeability%20in%20drug%20discovery%20and%20development%20settings&amp;author=C.%20A.%20Lipinski&amp;author=F.%20Lombardo&amp;author=B.%20W.%20Dominy&amp;author=P.%20J.%20Feeney&amp;volume=23&amp;issue=1%E2%80%933&amp;publication_year=1997&amp;pages=3-25&amp;pmid=11259830&amp;doi=10.1016/s0169-409x(00)00129-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit28">
<cite>Murad H. A. S. Alqurashi T. M. A. Hussien M. A. Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study. BMC Complementary Med. Ther. 2022;22(1):35. doi: 10.1186/s12906-021-03488-8.</cite> [<a href="https://doi.org/10.1186/s12906-021-03488-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8817505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35120520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Complementary%20Med.%20Ther.&amp;title=Interactions%20of%20selected%20cardiovascular%20active%20natural%20compounds%20with%20CXCR4%20and%20CXCR7%20receptors:%20a%20molecular%20docking,%20molecular%20dynamics,%20and%20pharmacokinetic/toxicity%20prediction%20study&amp;author=H.%20A.%20S.%20Murad&amp;author=T.%20M.%20A.%20Alqurashi&amp;author=M.%20A.%20Hussien&amp;volume=22&amp;issue=1&amp;publication_year=2022&amp;pages=35&amp;pmid=35120520&amp;doi=10.1186/s12906-021-03488-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit29">
<cite>Maliar T. Maliarová M. Purdešová A. Jankech T. Gerhardtová I. Beňovič P. 
et al., The adapted POM analysis of avenanthramides in silico. Pharmaceuticals. 2023;16(5):717. doi: 10.3390/ph16050717.</cite> [<a href="https://doi.org/10.3390/ph16050717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10224542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37242500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=et%20al.,%20The%20adapted%20POM%20analysis%20of%20avenanthramides%20in%20silico&amp;author=T.%20Maliar&amp;author=M.%20Maliarov%C3%A1&amp;author=A.%20Purde%C5%A1ov%C3%A1&amp;author=T.%20Jankech&amp;author=I.%20Gerhardtov%C3%A1&amp;volume=16&amp;issue=5&amp;publication_year=2023&amp;pages=717&amp;pmid=37242500&amp;doi=10.3390/ph16050717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit30">
<cite>Shehab W. S. Amer M. M. Elsayed D. A. Yadav K. K. Abdellattif M. H. Current progress toward synthetic routes and medicinal significance of quinoline. Med. Chem. Res. 2023;32(12):2443–2457.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Chem.%20Res.&amp;title=Current%20progress%20toward%20synthetic%20routes%20and%20medicinal%20significance%20of%20quinoline&amp;author=W.%20S.%20Shehab&amp;author=M.%20M.%20Amer&amp;author=D.%20A.%20Elsayed&amp;author=K.%20K.%20Yadav&amp;author=M.%20H.%20Abdellattif&amp;volume=32&amp;issue=12&amp;publication_year=2023&amp;pages=2443-2457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit31">
<cite>Kiefer F. Arnold K. Künzli M. Bordoli L. Schwede T. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res. 2009;37(suppl_1):D387–D392. doi: 10.1093/nar/gkn750.</cite> [<a href="https://doi.org/10.1093/nar/gkn750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2686475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18931379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=The%20SWISS-MODEL%20Repository%20and%20associated%20resources&amp;author=F.%20Kiefer&amp;author=K.%20Arnold&amp;author=M.%20K%C3%BCnzli&amp;author=L.%20Bordoli&amp;author=T.%20Schwede&amp;volume=37&amp;issue=suppl_1&amp;publication_year=2009&amp;pages=D387-D392&amp;pmid=18931379&amp;doi=10.1093/nar/gkn750&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit32">
<cite>McTigue M. Murray B. W. Chen J. H. Deng Y.-L. Solowiej J. Kania R. S. Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2012;109(45):18281–18289. doi: 10.1073/pnas.1207759109.</cite> [<a href="https://doi.org/10.1073/pnas.1207759109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3494931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22988103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.&amp;title=Molecular%20conformations,%20interactions,%20and%20properties%20associated%20with%20drug%20efficiency%20and%20clinical%20performance%20among%20VEGFR%20TK%20inhibitors&amp;author=M.%20McTigue&amp;author=B.%20W.%20Murray&amp;author=J.%20H.%20Chen&amp;author=Y.-L.%20Deng&amp;author=J.%20Solowiej&amp;volume=109&amp;issue=45&amp;publication_year=2012&amp;pages=18281-18289&amp;pmid=22988103&amp;doi=10.1073/pnas.1207759109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit33">
<cite>Labute P. Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins: Struct., Funct., Bioinf. 2009;75(1):187–205. doi: 10.1002/prot.22234.</cite> [<a href="https://doi.org/10.1002/prot.22234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3056144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18814299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteins:%20Struct.,%20Funct.,%20Bioinf.&amp;title=Protonate3D:%20assignment%20of%20ionization%20states%20and%20hydrogen%20coordinates%20to%20macromolecular%20structures&amp;author=P.%20Labute&amp;volume=75&amp;issue=1&amp;publication_year=2009&amp;pages=187-205&amp;pmid=18814299&amp;doi=10.1002/prot.22234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit34">
<cite>Yahya R. Al-Rajhi A. M. Alzaid S. Z. Al Abboud M. A. Almuhayawi M. S. Al Jaouni S. K. 
et al., Molecular docking and efficacy of Aloe vera gel based on chitosan nanoparticles against Helicobacter pylori and its antioxidant and anti-inflammatory activities. Polymers. 2022;14(15):2994. doi: 10.3390/polym14152994.</cite> [<a href="https://doi.org/10.3390/polym14152994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9330094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35893958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Polymers&amp;title=et%20al.,%20Molecular%20docking%20and%20efficacy%20of%20Aloe%20vera%20gel%20based%20on%20chitosan%20nanoparticles%20against%20Helicobacter%20pylori%20and%20its%20antioxidant%20and%20anti-inflammatory%20activities&amp;author=R.%20Yahya&amp;author=A.%20M.%20Al-Rajhi&amp;author=S.%20Z.%20Alzaid&amp;author=M.%20A.%20Al%20Abboud&amp;author=M.%20S.%20Almuhayawi&amp;volume=14&amp;issue=15&amp;publication_year=2022&amp;pages=2994&amp;pmid=35893958&amp;doi=10.3390/polym14152994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit35">
<cite>Divyashri G. Murthy T. K. Sundareshan S. Kamath P. Murahari M. Saraswathy G. 
et al., In silico approach towards the identification of potential inhibitors from Curcuma amada Roxb against H. pylori: ADMET screening and molecular docking studies. BioImpacts: BI. 2021;11(2):119. doi: 10.34172/bi.2021.19.</cite> [<a href="https://doi.org/10.34172/bi.2021.19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8022237/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33842282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioImpacts:%20BI&amp;title=et%20al.,%20In%20silico%20approach%20towards%20the%20identification%20of%20potential%20inhibitors%20from%20Curcuma%20amada%20Roxb%20against%20H.%20pylori:%20ADMET%20screening%20and%20molecular%20docking%20studies&amp;author=G.%20Divyashri&amp;author=T.%20K.%20Murthy&amp;author=S.%20Sundareshan&amp;author=P.%20Kamath&amp;author=M.%20Murahari&amp;volume=11&amp;issue=2&amp;publication_year=2021&amp;pages=119&amp;pmid=33842282&amp;doi=10.34172/bi.2021.19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit36">
<cite>Elmaaty A. Hamed M. Ismail M. Elkaeed E. Abulkhair H. Khattab M. 
et al., Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization. Molecules. 2021;26:3772. doi: 10.3390/molecules26123772.</cite> [<a href="https://doi.org/10.3390/molecules26123772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8234583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34205704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=et%20al.,%20Computational%20Insights%20on%20the%20Potential%20of%20Some%20NSAIDs%20for%20Treating%20COVID-19:%20Priority%20Set%20and%20Lead%20Optimization&amp;author=A.%20Elmaaty&amp;author=M.%20Hamed&amp;author=M.%20Ismail&amp;author=E.%20Elkaeed&amp;author=H.%20Abulkhair&amp;volume=26&amp;publication_year=2021&amp;pages=3772&amp;pmid=34205704&amp;doi=10.3390/molecules26123772&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit37">
<cite>Alesawy M. S. Al-Karmalawy A. A. Elkaeed E. B. Alswah M. Belal A. Taghour M. S. 
et al., Design and discovery of new 1, 2, 4-triazolo [4, 3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Pharm. 2021;354(3):2000237. doi: 10.1002/ardp.202000237.</cite> [<a href="https://doi.org/10.1002/ardp.202000237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33226150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Pharm.&amp;title=et%20al.,%20Design%20and%20discovery%20of%20new%201,%202,%204-triazolo%20%5B4,%203-c%5D%20quinazolines%20as%20potential%20DNA%20intercalators%20and%20topoisomerase%20II%20inhibitors&amp;author=M.%20S.%20Alesawy&amp;author=A.%20A.%20Al-Karmalawy&amp;author=E.%20B.%20Elkaeed&amp;author=M.%20Alswah&amp;author=A.%20Belal&amp;volume=354&amp;issue=3&amp;publication_year=2021&amp;pages=2000237&amp;pmid=33226150&amp;doi=10.1002/ardp.202000237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit38">
<cite>Hamed E. O. Assy M. G. Ouf N. H. Elsayed D. A. Abdellattif M. H. Cyclization of N-acetyl derivative: Novel synthesis–azoles and azines, antimicrobial activities, and computational studies. Heterocycl. Commun. 2022;28(1):35–43.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Heterocycl.%20Commun.&amp;title=Cyclization%20of%20N-acetyl%20derivative:%20Novel%20synthesis%E2%80%93azoles%20and%20azines,%20antimicrobial%20activities,%20and%20computational%20studies&amp;author=E.%20O.%20Hamed&amp;author=M.%20G.%20Assy&amp;author=N.%20H.%20Ouf&amp;author=D.%20A.%20Elsayed&amp;author=M.%20H.%20Abdellattif&amp;volume=28&amp;issue=1&amp;publication_year=2022&amp;pages=35-43&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit39">
<cite>Hamed E. O. Elsayed D. A. Assy M. G. Shehab W. S. Design, Synthesis, Docking, 2D-QSAR Modelling, Anticancer and Antioxidant Evaluation of Some New Azo-Compounds Derivatives and Investigation of Their Fluorescence Properties. ChemistrySelect. 2022;7(41):e202202534.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=ChemistrySelect&amp;title=Design,%20Synthesis,%20Docking,%202D-QSAR%20Modelling,%20Anticancer%20and%20Antioxidant%20Evaluation%20of%20Some%20New%20Azo-Compounds%20Derivatives%20and%20Investigation%20of%20Their%20Fluorescence%20Properties&amp;author=E.%20O.%20Hamed&amp;author=D.%20A.%20Elsayed&amp;author=M.%20G.%20Assy&amp;author=W.%20S.%20Shehab&amp;volume=7&amp;issue=41&amp;publication_year=2022&amp;pages=e202202534&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit40">
<cite>Aziz M. A. Shehab W. S. Al-Karmalawy A. A. El-Farargy A. F. Abdellattif M. H. Design, Synthesis, Biological Evaluation, 2D-QSAR Modeling, and Molecular Docking Studies of Novel 1H-3-Indolyl Derivatives as Significant Antioxidants. Int. J. Mol. Sci. 2021;22(19):10396. doi: 10.3390/ijms221910396.</cite> [<a href="https://doi.org/10.3390/ijms221910396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8508798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34638734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Design,%20Synthesis,%20Biological%20Evaluation,%202D-QSAR%20Modeling,%20and%20Molecular%20Docking%20Studies%20of%20Novel%201H-3-Indolyl%20Derivatives%20as%20Significant%20Antioxidants&amp;author=M.%20A.%20Aziz&amp;author=W.%20S.%20Shehab&amp;author=A.%20A.%20Al-Karmalawy&amp;author=A.%20F.%20El-Farargy&amp;author=M.%20H.%20Abdellattif&amp;volume=22&amp;issue=19&amp;publication_year=2021&amp;pages=10396&amp;pmid=34638734&amp;doi=10.3390/ijms221910396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit41">
<cite>Singh P. Kumar R. Tiwari S. Khanna R. Tewari A. Khanna H. Docking, synthesis and evaluation of antioxidant activity of 2, 4, 5-triaryl imidazole. Clin. Med. Biochem. 2015;1(105):2471–2663.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Med.%20Biochem.&amp;title=Docking,%20synthesis%20and%20evaluation%20of%20antioxidant%20activity%20of%202,%204,%205-triaryl%20imidazole&amp;author=P.%20Singh&amp;author=R.%20Kumar&amp;author=S.%20Tiwari&amp;author=R.%20Khanna&amp;author=A.%20Tewari&amp;volume=1&amp;issue=105&amp;publication_year=2015&amp;pages=2471-2663&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit42">
<cite>Anwer K. E. Sayed G. H. Essa B. M. Selim A. A. Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy. BMC Chem. 2023;17(1):139. doi: 10.1186/s13065-023-01053-7.</cite> [<a href="https://doi.org/10.1186/s13065-023-01053-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10585773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37853452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Chem.&amp;title=Green%20synthesis%20of%20highly%20functionalized%20heterocyclic%20bearing%20pyrazole%20moiety%20for%20cancer-targeted%20chemo/radioisotope%20therapy&amp;author=K.%20E.%20Anwer&amp;author=G.%20H.%20Sayed&amp;author=B.%20M.%20Essa&amp;author=A.%20A.%20Selim&amp;volume=17&amp;issue=1&amp;publication_year=2023&amp;pages=139&amp;pmid=37853452&amp;doi=10.1186/s13065-023-01053-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit43">
<cite>Sanad M. Eyssa H. Marzook F. Farag A. Rizvi S. Mandal S. 
et al., Optimized chromatographic separation and bioevalution of radioiodinated ilaprazole as a new labeled compound for peptic ulcer localization in mice. Radiochemistry. 2021;63(6):811–819.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochemistry&amp;title=et%20al.,%20Optimized%20chromatographic%20separation%20and%20bioevalution%20of%20radioiodinated%20ilaprazole%20as%20a%20new%20labeled%20compound%20for%20peptic%20ulcer%20localization%20in%20mice&amp;author=M.%20Sanad&amp;author=H.%20Eyssa&amp;author=F.%20Marzook&amp;author=A.%20Farag&amp;author=S.%20Rizvi&amp;volume=63&amp;issue=6&amp;publication_year=2021&amp;pages=811-819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit44">
<cite>Marzook E. A. El-Bayoumy A. S. Marzook F. A. Preclinical evaluation of carnosine and Costus as hematological protective agents against gamma radiation. J. Radiat. Res. Appl. Sci. 2019;12(1):304–310.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Radiat.%20Res.%20Appl.%20Sci.&amp;title=Preclinical%20evaluation%20of%20carnosine%20and%20Costus%20as%20hematological%20protective%20agents%20against%20gamma%20radiation&amp;author=E.%20A.%20Marzook&amp;author=A.%20S.%20El-Bayoumy&amp;author=F.%20A.%20Marzook&amp;volume=12&amp;issue=1&amp;publication_year=2019&amp;pages=304-310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit45">
<cite>Sanad M. Marzook F. A. Farag A. B. Mandal S. K. Rizvi S. F. Gupta J. K. Preparation, biological evaluation and radiolabeling of [99mTc]-technetium tricarbonyl procainamide as a tracer for heart imaging in mice. Radiochim. Acta. 2022;110(4):267–277.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochim.%20Acta&amp;title=Preparation,%20biological%20evaluation%20and%20radiolabeling%20of%20%5B99mTc%5D-technetium%20tricarbonyl%20procainamide%20as%20a%20tracer%20for%20heart%20imaging%20in%20mice&amp;author=M.%20Sanad&amp;author=F.%20A.%20Marzook&amp;author=A.%20B.%20Farag&amp;author=S.%20K.%20Mandal&amp;author=S.%20F.%20Rizvi&amp;volume=110&amp;issue=4&amp;publication_year=2022&amp;pages=267-277&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit46">
<cite>Sanad M. Eyssa H. Marzook F. Farag A. Preparation and bioevaluation of [99mTc] tricarbonyl omeprazole for gastric ulcer localization in mice. Radiochemistry. 2022;64(1):54–61.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Radiochemistry&amp;title=Preparation%20and%20bioevaluation%20of%20%5B99mTc%5D%20tricarbonyl%20omeprazole%20for%20gastric%20ulcer%20localization%20in%20mice&amp;author=M.%20Sanad&amp;author=H.%20Eyssa&amp;author=F.%20Marzook&amp;author=A.%20Farag&amp;volume=64&amp;issue=1&amp;publication_year=2022&amp;pages=54-61&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit47">
<cite>Sanad M. Eyssa H. Marzook F. Farag A. Rizvi S. Radioiodinated procainamide as radiotracer for myocardial perfusion imaging in mice. Pharm. Chem. J. 2023;57(4):543–549.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm.%20Chem.%20J.&amp;title=Radioiodinated%20procainamide%20as%20radiotracer%20for%20myocardial%20perfusion%20imaging%20in%20mice&amp;author=M.%20Sanad&amp;author=H.%20Eyssa&amp;author=F.%20Marzook&amp;author=A.%20Farag&amp;author=S.%20Rizvi&amp;volume=57&amp;issue=4&amp;publication_year=2023&amp;pages=543-549&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit48">
<cite>David E. M. Pacharinsak C. Jampachaisri K. Hagan L. Marx J. O. Use of ketamine or xylazine to provide balanced anesthesia with isoflurane in C57BL/6J mice. J. Am. Assoc. Lab. Anim. Sci. 2022;61(5):457–467. doi: 10.30802/AALAS-JAALAS-21-000125.</cite> [<a href="https://doi.org/10.30802/AALAS-JAALAS-21-000125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9536832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35940848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Assoc.%20Lab.%20Anim.%20Sci.&amp;title=Use%20of%20ketamine%20or%20xylazine%20to%20provide%20balanced%20anesthesia%20with%20isoflurane%20in%20C57BL/6J%20mice&amp;author=E.%20M.%20David&amp;author=C.%20Pacharinsak&amp;author=K.%20Jampachaisri&amp;author=L.%20Hagan&amp;author=J.%20O.%20Marx&amp;volume=61&amp;issue=5&amp;publication_year=2022&amp;pages=457-467&amp;pmid=35940848&amp;doi=10.30802/AALAS-JAALAS-21-000125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit49">
<cite>Kashyap A. Choudhury A. A. Saha A. Adhikari N. Ghosh S. K. Shakya A. 
et al., Microwave-assisted synthesis of hybrid PABA-1, 3, 5-triazine derivatives as an antimalarial agent. J. Biochem. Mol. Toxicol. 2021;35(9):e22860. doi: 10.1002/jbt.22860.</cite> [<a href="https://doi.org/10.1002/jbt.22860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34313355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biochem.%20Mol.%20Toxicol.&amp;title=et%20al.,%20Microwave-assisted%20synthesis%20of%20hybrid%20PABA-1,%203,%205-triazine%20derivatives%20as%20an%20antimalarial%20agent&amp;author=A.%20Kashyap&amp;author=A.%20A.%20Choudhury&amp;author=A.%20Saha&amp;author=N.%20Adhikari&amp;author=S.%20K.%20Ghosh&amp;volume=35&amp;issue=9&amp;publication_year=2021&amp;pages=e22860&amp;pmid=34313355&amp;doi=10.1002/jbt.22860&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit50">
<cite>Batool I. Saeed A. Qureshi I. Z. Kalsoom S. Razzaq A. Synthesis, molecular docking and biological evaluation of new thiazolopyrimidine carboxylates as potential antidiabetic and antibacterial agents. Res. Chem. Intermed. 2016;42(2):1139–1163.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Chem.%20Intermed.&amp;title=Synthesis,%20molecular%20docking%20and%20biological%20evaluation%20of%20new%20thiazolopyrimidine%20carboxylates%20as%20potential%20antidiabetic%20and%20antibacterial%20agents&amp;author=I.%20Batool&amp;author=A.%20Saeed&amp;author=I.%20Z.%20Qureshi&amp;author=S.%20Kalsoom&amp;author=A.%20Razzaq&amp;volume=42&amp;issue=2&amp;publication_year=2016&amp;pages=1139-1163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit51">
<cite>Hassaballah A. I. El-Ziaty A. Gado M. M. Sayed H. A. Kamal M. Ali R. S. Design synthesis, characterization, molecular docking and antimicrobial evaluation of novel heterocycles with acrylonitrile and anthracene moieties. Sci. Rep. 2025;15(1):19370. doi: 10.1038/s41598-025-03272-5.</cite> [<a href="https://doi.org/10.1038/s41598-025-03272-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12134333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40461523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Design%20synthesis,%20characterization,%20molecular%20docking%20and%20antimicrobial%20evaluation%20of%20novel%20heterocycles%20with%20acrylonitrile%20and%20anthracene%20moieties&amp;author=A.%20I.%20Hassaballah&amp;author=A.%20El-Ziaty&amp;author=M.%20M.%20Gado&amp;author=H.%20A.%20Sayed&amp;author=M.%20Kamal&amp;volume=15&amp;issue=1&amp;publication_year=2025&amp;pages=19370&amp;pmid=40461523&amp;doi=10.1038/s41598-025-03272-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit52">
<cite>Jang S. F. Goins B. A. Phillips W. T. Santoyo C. Rice-Ficht A. McConville J. T. Size discrimination in rat and mouse gastric emptying. Biopharm. Drug Dispos. 2013;34(2):107–124. doi: 10.1002/bdd.1828.</cite> [<a href="https://doi.org/10.1002/bdd.1828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23143681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biopharm.%20Drug%20Dispos.&amp;title=Size%20discrimination%20in%20rat%20and%20mouse%20gastric%20emptying&amp;author=S.%20F.%20Jang&amp;author=B.%20A.%20Goins&amp;author=W.%20T.%20Phillips&amp;author=C.%20Santoyo&amp;author=A.%20Rice-Ficht&amp;volume=34&amp;issue=2&amp;publication_year=2013&amp;pages=107-124&amp;pmid=23143681&amp;doi=10.1002/bdd.1828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit53">
<cite>Yee H. S. Fong N. T. A review of the safety and efficacy of acarbose in diabetes mellitus. Pharmacotherapy. 1996;16(5):792–805.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8888075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacotherapy&amp;title=A%20review%20of%20the%20safety%20and%20efficacy%20of%20acarbose%20in%20diabetes%20mellitus&amp;author=H.%20S.%20Yee&amp;author=N.%20T.%20Fong&amp;volume=16&amp;issue=5&amp;publication_year=1996&amp;pages=792-805&amp;pmid=8888075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit54">
<cite>Giovanella L. Avram A. M. Ovčariček P. P. Clerc J. Thyroid functional and molecular imaging. Presse Med. 2022;51(2):104116. doi: 10.1016/j.lpm.2022.104116.</cite> [<a href="https://doi.org/10.1016/j.lpm.2022.104116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35124101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Presse%20Med.&amp;title=Thyroid%20functional%20and%20molecular%20imaging&amp;author=L.%20Giovanella&amp;author=A.%20M.%20Avram&amp;author=P.%20P.%20Ov%C4%8Dari%C4%8Dek&amp;author=J.%20Clerc&amp;volume=51&amp;issue=2&amp;publication_year=2022&amp;pages=104116&amp;pmid=35124101&amp;doi=10.1016/j.lpm.2022.104116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit55">
<cite>Abdelhakeem E. Nemr A. A. Rashed H. M. Selim A. A. Essa B. M. Hegazy D. Revitalizing itraconazole: Unleashing its anticancer potential through oral nanosystems for liver targeting and biodistribution profiling in an animal model using radiolabeling technique. J. Drug Delivery Sci. Technol. 2025;104:106463.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Drug%20Delivery%20Sci.%20Technol.&amp;title=Revitalizing%20itraconazole:%20Unleashing%20its%20anticancer%20potential%20through%20oral%20nanosystems%20for%20liver%20targeting%20and%20biodistribution%20profiling%20in%20an%20animal%20model%20using%20radiolabeling%20technique&amp;author=E.%20Abdelhakeem&amp;author=A.%20A.%20Nemr&amp;author=H.%20M.%20Rashed&amp;author=A.%20A.%20Selim&amp;author=B.%20M.%20Essa&amp;volume=104&amp;publication_year=2025&amp;pages=106463&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>RA-015-D5RA04955E-s001</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12376908/bin/RA-015-D5RA04955E-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">RA-015-D5RA04955E-s001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data supporting this article have been included as part of the SI.</p>
<p>The SI includes detailed experimental procedures, full characterization data of the synthesized compounds (<sup>1</sup>H NMR, <sup>13</sup>C NMR, IR spectra). See DOI: <a href="https://doi.org/10.1039/d5ra04955e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1039/d5ra04955e</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from RSC Advances are provided here courtesy of <strong>Royal Society of Chemistry</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1039/d5ra04955e"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/RA-015-D5RA04955E.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12376908/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12376908/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12376908%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376908/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12376908/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12376908/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12376908/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12376908/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12376908/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tMx8jzEE3uK7LUEFDuaJI3x6dqTUTJEyukgUmRDlozhqW4MkA1sx8zbOBe8KUijt">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
